A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg).
Glucose in blood.
A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.
A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.
A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1).
Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).
Abstaining from all food.
Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.
A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin.
A type of pancreatic cell representing about 50-80% of the islet cells. Beta cells secrete INSULIN.
Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL.
A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Abnormally high BLOOD GLUCOSE level.
Substances which lower blood glucose levels.
Pathological conditions in which the BLOOD GLUCOSE cannot be maintained within the normal range, such as in HYPOGLYCEMIA and HYPERGLYCEMIA. Etiology of these disorders varies. Plasma glucose concentration is critical to survival for it is the predominant fuel for the CENTRAL NERVOUS SYSTEM.
Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN.
Maintenance of a constant blood glucose level by perfusion or infusion with glucose or insulin. It is used for the study of metabolic rates (e.g., in glucose, lipid, amino acid metabolism) at constant glucose concentration.
A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.
The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc.
A peptide of 36 or 37 amino acids that is derived from PROGLUCAGON and mainly produced by the INTESTINAL L CELLS. GLP-1(1-37 or 1-36) is further N-terminally truncated resulting in GLP-1(7-37) or GLP-1-(7-36) which can be amidated. These GLP-1 peptides are known to enhance glucose-dependent INSULIN release, suppress GLUCAGON release and gastric emptying, lower BLOOD GLUCOSE, and reduce food intake.
Minor hemoglobin components of human erythrocytes designated A1a, A1b, and A1c. Hemoglobin A1c is most important since its sugar moiety is glucose covalently bound to the terminal amino acid of the beta chain. Since normal glycohemoglobin concentrations exclude marked blood glucose fluctuations over the preceding three to four weeks, the concentration of glycosylated hemoglobin A is a more reliable index of the blood sugar average over a long period of time.
The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511)
An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight (kg)/height squared (m2). BMI correlates with body fat (ADIPOSE TISSUE). Their relationship varies with age and gender. For adults, BMI falls into these categories: below 18.5 (underweight); 18.5-24.9 (normal); 25.0-29.9 (overweight); 30.0 and above (obese). (National Center for Health Statistics, Centers for Disease Control and Prevention)
FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form.
Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white.
A measure of a patient's ability to break down lactose.
The processes whereby the internal environment of an organism tends to remain balanced and stable.
A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.
A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed)
A glucose transport protein found in mature MUSCLE CELLS and ADIPOCYTES. It promotes transport of glucose from the BLOOD into target TISSUES. The inactive form of the protein is localized in CYTOPLASMIC VESICLES. In response to INSULIN, it is translocated to the PLASMA MEMBRANE where it facilitates glucose uptake.
The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality.
A statistical means of summarizing information from a series of measurements on one individual. It is frequently used in clinical pharmacology where the AUC from serum levels can be interpreted as the total uptake of whatever has been administered. As a plot of the concentration of a drug against time, after a single dose of medicine, producing a standard shape curve, it is a means of comparing the bioavailability of the same drug made by different companies. (From Winslade, Dictionary of Clinical Research, 1992)
The relative amounts of various components in the body, such as percentage of body fat.
The time frame after a meal or FOOD INTAKE.
A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80)
Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY.
A pancreatic polypeptide of about 110 amino acids, depending on the species, that is the precursor of insulin. Proinsulin, produced by the PANCREATIC BETA CELLS, is comprised sequentially of the N-terminal B-chain, the proteolytically removable connecting C-peptide, and the C-terminal A-chain. It also contains three disulfide bonds, two between A-chain and B-chain. After cleavage at two locations, insulin and C-peptide are the secreted products. Intact proinsulin with low bioactivity also is secreted in small amounts.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
A gastrointestinal peptide hormone of about 43-amino acids. It is found to be a potent stimulator of INSULIN secretion and a relatively poor inhibitor of GASTRIC ACID secretion.
The appearance of an abnormally large amount of GLUCOSE in the urine, such as more than 500 mg/day in adults. It can be due to HYPERGLYCEMIA or genetic defects in renal reabsorption (RENAL GLYCOSURIA).
Elements of limited time intervals, contributing to particular results or situations.
A subtype of striated muscle, attached by TENDONS to the SKELETON. Skeletal muscles are innervated and their movement can be consciously controlled. They are also called voluntary muscles.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados.
Two populations of Zucker rats have been cited in research--the "fatty" or obese and the lean. The "fatty" rat (Rattus norvegicus) appeared as a spontaneous mutant. The obese condition appears to be due to a single recessive gene.
Peptides which stimulate INSULIN release from the PANCREATIC BETA CELLS following oral nutrient ingestion, or postprandially.
A 30-kDa COMPLEMENT C1Q-related protein, the most abundant gene product secreted by FAT CELLS of the white ADIPOSE TISSUE. Adiponectin modulates several physiological processes, such as metabolism of GLUCOSE and FATTY ACIDS, and immune responses. Decreased plasma adiponectin levels are associated with INSULIN RESISTANCE; TYPE 2 DIABETES MELLITUS; OBESITY; and ATHEROSCLEROSIS.
A cluster of metabolic risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome X include excess ABDOMINAL FAT; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. (from AHA/NHLBI/ADA Conference Proceedings, Circulation 2004; 109:551-556)
A glucose transport facilitator that is expressed primarily in PANCREATIC BETA CELLS; LIVER; and KIDNEYS. It may function as a GLUCOSE sensor to regulate INSULIN release and glucose HOMEOSTASIS.
The consumption of edible substances.
The amount of fat or lipid deposit at a site or an organ in the body, an indicator of body fat status.
Methods and procedures for the diagnosis of diseases or dysfunction of the endocrine glands or demonstration of their physiological processes.
A 191-amino acid polypeptide hormone secreted by the human adenohypophysis (PITUITARY GLAND, ANTERIOR), also known as GH or somatotropin. Synthetic growth hormone, termed somatropin, has replaced the natural form in therapeutic usage such as treatment of dwarfism in children with growth hormone deficiency.
Carbohydrates present in food comprising digestible sugars and starches and indigestible cellulose and other dietary fibers. The former are the major source of energy. The sugars are in beet and cane sugar, fruits, honey, sweet corn, corn syrup, milk and milk products, etc.; the starches are in cereal grains, legumes (FABACEAE), tubers, etc. (From Claudio & Lagua, Nutrition and Diet Therapy Dictionary, 3d ed, p32, p277)
Consumption of excessive DIETARY FATS.
In females, the period that is shortly after giving birth (PARTURITION).
A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.
A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
A 16-kDa peptide hormone secreted from WHITE ADIPOCYTES. Leptin serves as a feedback signal from fat cells to the CENTRAL NERVOUS SYSTEM in regulation of food intake, energy balance, and fat storage.
A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
A large group of membrane transport proteins that shuttle MONOSACCHARIDES across CELL MEMBRANES.
The physical characteristics of the body, including the mode of performance of functions, the activity of metabolic processes, the manner and degree of reactions to stimuli, and power of resistance to the attack of pathogenic organisms.
A monosaccharide in sweet fruits and honey that is soluble in water, alcohol, or ether. It is used as a preservative and an intravenous infusion in parenteral feeding.
Physiological processes in biosynthesis (anabolism) and degradation (catabolism) of LIPIDS.
An enzyme of the oxidoreductase class that catalyzes the conversion of beta-D-glucose and oxygen to D-glucono-1,5-lactone and peroxide. It is a flavoprotein, highly specific for beta-D-glucose. The enzyme is produced by Penicillium notatum and other fungi and has antibacterial activity in the presence of glucose and oxygen. It is used to estimate glucose concentration in blood or urine samples through the formation of colored dyes by the hydrogen peroxide produced in the reaction. (From Enzyme Nomenclature, 1992) EC 1.1.3.4.
The chemical reactions involved in the production and utilization of various forms of energy in cells.
A trace element that plays a role in glucose metabolism. It has the atomic symbol Cr, atomic number 24, and atomic weight 52. According to the Fourth Annual Report on Carcinogens (NTP85-002,1985), chromium and some of its compounds have been listed as known carcinogens.
A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
A ubiquitously expressed glucose transporter that is important for constitutive, basal GLUCOSE transport. It is predominately expressed in ENDOTHELIAL CELLS and ERYTHROCYTES at the BLOOD-BRAIN BARRIER and is responsible for GLUCOSE entry into the BRAIN.
2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity.
Cellular processes in biosynthesis (anabolism) and degradation (catabolism) of CARBOHYDRATES.
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
Fatty tissue inside the ABDOMINAL CAVITY, including visceral fat and retroperitoneal fat. It is the most metabolically active fat in the body and easily accessible for LIPOLYSIS. Increased visceral fat is associated with metabolic complications of OBESITY.
The giving of drugs, chemicals, or other substances by mouth.
Mutant mice exhibiting a marked obesity coupled with overeating, hyperglycemia, hyperinsulinemia, marked insulin resistance, and infertility when in a homozygous state. They may be inbred or hybrid.
Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.
One of the Indian Ocean Islands, east of Madagascar. Its capital is Port Louis. It was discovered by the Portuguese in 1505, occupied by the Dutch 1598-1710, held by the French 1715-1810 when the British captured it, formally ceded to the British in 1814, and became independent in 1968. It was named by the Dutch in honor of Maurice of Nassau, Prince of Orange (1567-1625). (From Webster's New Geographical Dictionary, 1988, p742 & Room, Brewer's Dictionary of Names, 1992, p341)
Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE.
The transference of pancreatic islets within an individual, between individuals of the same species, or between individuals of different species.
PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.
A status with BODY WEIGHT that is above certain standard of acceptable or desirable weight. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal "over fat".
THIAZOLES with two keto oxygens. Members are insulin-sensitizing agents which overcome INSULIN RESISTANCE by activation of the peroxisome proliferator activated receptor gamma (PPAR-gamma).
Non-profit organizations concerned with various aspects of health, e.g., education, promotion, treatment, services, etc.
A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.
Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable.
An induced state of non-reactivity to grafted tissue from a donor organism that would ordinarily trigger a cell-mediated or humoral immune response.
Regular course of eating and drinking adopted by a person or animal.
Cell surface receptors that bind glucagon with high affinity and trigger intracellular changes which influence the behavior of cells. Activation of glucagon receptors causes a variety of effects; the best understood is the initiation of a complex enzymatic cascade in the liver which ultimately increases the availability of glucose to body organs.
A group of enzymes that catalyzes the conversion of ATP and D-glucose to ADP and D-glucose 6-phosphate. They are found in invertebrates and microorganisms, and are highly specific for glucose. (Enzyme Nomenclature, 1992) EC 2.7.1.2.
Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals.
A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized.
The technique that deals with the measurement of the size, weight, and proportions of the human or other primate body.
Individuals whose ancestral origins are in the continent of Europe.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Increase in BODY WEIGHT over existing weight.
The state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy (DIABETES, GESTATIONAL) which resolves at the end of pregnancy.
Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.
A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
An amino sugar formed when glucose non-enzymatically reacts with the N-terminal amino group of proteins. The fructose moiety is derived from glucose by the "classical" Amadori rearrangement.
Biosynthesis of GLUCOSE from nonhexose or non-carbohydrate precursors, such as LACTATE; PYRUVATE; ALANINE; and GLYCEROL.
A condition caused by the excessive secretion of ANDROGENS from the ADRENAL CORTEX; the OVARIES; or the TESTES. The clinical significance in males is negligible. In women, the common manifestations are HIRSUTISM and VIRILISM as seen in patients with POLYCYSTIC OVARY SYNDROME and ADRENOCORTICAL HYPERFUNCTION.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
A 28-amino acid, acylated, orexigenic peptide that is a ligand for GROWTH HORMONE SECRETAGOGUE RECEPTORS. Ghrelin is widely expressed but primarily in the stomach in the adults. Ghrelin acts centrally to stimulate growth hormone secretion and food intake, and peripherally to regulate energy homeostasis. Its large precursor protein, known as appetite-regulating hormone or motilin-related peptide, contains ghrelin and obestatin.
Any of the large interior organs in any one of the three great cavities of the body, especially in the abdomen.
Total number of calories taken in daily whether ingested or by parenteral routes.
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression.
Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed)
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.
Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol.
Decrease in existing BODY WEIGHT.
Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Physical activity which is usually regular and done with the intention of improving or maintaining PHYSICAL FITNESS or HEALTH. Contrast with PHYSICAL EXERTION which is concerned largely with the physiologic and metabolic response to energy expenditure.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
Fatty tissue in the region of the ABDOMEN. It includes the ABDOMINAL SUBCUTANEOUS FAT and the INTRA-ABDOMINAL FAT.
The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
The relationship between the dose of an administered drug and the response of the organism to the drug.
A structurally-related group of signaling proteins that are phosphorylated by the INSULIN RECEPTOR PROTEIN-TYROSINE KINASE. The proteins share in common an N-terminal PHOSPHOLIPID-binding domain, a phosphotyrosine-binding domain that interacts with the phosphorylated INSULIN RECEPTOR, and a C-terminal TYROSINE-rich domain. Upon tyrosine phosphorylation insulin receptor substrate proteins interact with specific SH2 DOMAIN-containing proteins that are involved in insulin receptor signaling.
The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.
The circulating form of a major C19 steroid produced primarily by the ADRENAL CORTEX. DHEA sulfate serves as a precursor for TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE.
The condition resulting from the absence or deficiency of LACTASE in the MUCOSA cells of the GASTROINTESTINAL TRACT, and the inability to break down LACTOSE in milk for ABSORPTION. Bacterial fermentation of the unabsorbed lactose leads to symptoms that range from a mild indigestion (DYSPEPSIA) to severe DIARRHEA. Lactose intolerance may be an inborn error or acquired.
Self evaluation of whole blood glucose levels outside the clinical laboratory. A digital or battery-operated reflectance meter may be used. It has wide application in controlling unstable insulin-dependent diabetes.
Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release.
A circumscribed melanosis consisting of a brown-pigmented, velvety verrucosity or fine papillomatosis appearing in the axillae and other body folds. It occurs in association with endocrine disorders, underlying malignancy, administration of certain drugs, or as in inherited disorder.
A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects.
Cells in the body that store FATS, usually in the form of TRIGLYCERIDES. WHITE ADIPOCYTES are the predominant type and found mostly in the abdominal cavity and subcutaneous tissue. BROWN ADIPOCYTES are thermogenic cells that can be found in newborns of some species and hibernating mammals.
Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
Individual members of North American ethnic groups with ancient historic ancestral origins in Asia.
The measurement around the body at the level of the ABDOMEN and just above the hip bone. The measurement is usually taken immediately after exhalation.
Surgical procedure in which the STOMACH is transected high on the body. The resulting small proximal gastric pouch is joined to any parts of the SMALL INTESTINE by an end-to-side SURGICAL ANASTOMOSIS, depending on the amounts of intestinal surface being bypasses. This procedure is used frequently in the treatment of MORBID OBESITY by limiting the size of functional STOMACH, food intake, and food absorption.
A numerical system of measuring the rate of BLOOD GLUCOSE generation from a particular food item as compared to a reference item, such as glucose = 100. Foods with higher glycemic index numbers create greater blood sugar swings.
A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE.
Organized periodic procedures performed on large groups of people for the purpose of detecting disease.
That portion of the body that lies between the THORAX and the PELVIS.
Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.
A glucose dehydrogenase that catalyzes the oxidation of beta-D-glucose to form D-glucono-1,5-lactone, using NAD as well as NADP as a coenzyme.
An unbranched glucan in starch.
Individuals whose ancestral origins are in the southeastern and eastern areas of the Asian continent.
A period in the human life in which the development of the hypothalamic-pituitary-gonadal system takes place and reaches full maturity. The onset of synchronized endocrine events in puberty lead to the capacity for reproduction (FERTILITY), development of secondary SEX CHARACTERISTICS, and other changes seen in ADOLESCENT DEVELOPMENT.
Persons living in the United States of Mexican (MEXICAN AMERICANS), Puerto Rican, Cuban, Central or South American, or other Spanish culture or origin. The concept does not include Brazilian Americans or Portuguese Americans.
A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula.
The rate dynamics in chemical or physical systems.
A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.
Polypeptides produced by the ADIPOCYTES. They include LEPTIN; ADIPONECTIN; RESISTIN; and many cytokines of the immune system, such as TUMOR NECROSIS FACTOR-ALPHA; INTERLEUKIN-6; and COMPLEMENT FACTOR D (also known as ADIPSIN). They have potent autocrine, paracrine, and endocrine functions.
Any of a group of polysaccharides of the general formula (C6-H10-O5)n, composed of a long-chain polymer of glucose in the form of amylose and amylopectin. It is the chief storage form of energy reserve (carbohydrates) in plants.
The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
A condition of fetal overgrowth leading to a large-for-gestational-age FETUS. It is defined as BIRTH WEIGHT greater than 4,000 grams or above the 90th percentile for population and sex-specific growth curves. It is commonly seen in GESTATIONAL DIABETES; PROLONGED PREGNANCY; and pregnancies complicated by pre-existing diabetes mellitus.
Antibodies specific to INSULIN.
The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it.
A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor.
The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.
The common precursor polypeptide of pancreatic GLUCAGON and intestinal GLUCAGON-LIKE PEPTIDES. Proglucagon is the 158-amino acid segment of preproglucagon without the N-terminal signal sequence. Proglucagon is expressed in the PANCREAS; INTESTINES; and the CENTRAL NERVOUS SYSTEM. Posttranslational processing of proglucagon is tissue-specific yielding numerous bioactive peptides.
An inhibitor of ALPHA-GLUCOSIDASES that retards the digestion and absorption of DIETARY CARBOHYDRATES in the SMALL INTESTINE.
The measurement of an organ in volume, mass, or heaviness.
Peptides derived from proglucagon which is also the precursor of pancreatic GLUCAGON. Despite expression of proglucagon in multiple tissues, the major production site of glucagon-like peptides (GLPs) is the INTESTINAL L CELLS. GLPs include glucagon-like peptide 1, glucagon-like peptide 2, and the various truncated forms.
A serine protease that catalyses the release of an N-terminal dipeptide. Several biologically-active peptides have been identified as dipeptidyl peptidase 4 substrates including INCRETINS; NEUROPEPTIDES; and CHEMOKINES. The protein is also found bound to ADENOSINE DEAMINASE on the T-CELL surface and is believed to play a role in T-cell activation.
The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346)
A tricyclo bridged hydrocarbon.
The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments.
Conditions with excess LIPIDS in the blood.
Retinol binding proteins that circulate in the PLASMA. They are members of the lipocalin family of proteins and play a role in the transport of RETINOL from the LIVER to the peripheral tissues. The proteins are usually found in association with TRANSTHYRETIN.
Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed)
A highly branched glucan in starch.
A diet prescribed in the treatment of diabetes mellitus, usually limited in the amount of sugar or readily available carbohydrate. (Dorland, 27th ed)
Sucrose present in the diet. It is added to food and drinks as a sweetener.
A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, and sweetening agent.
A condition of elevated levels of TRIGLYCERIDES in the blood.
Hormones released from neoplasms or from other cells that are not the usual sources of hormones.
Any substances taken in by the body that provide nourishment.
A metabolite of PROGESTERONE with a hydroxyl group at the 17-alpha position. It serves as an intermediate in the biosynthesis of HYDROCORTISONE and GONADAL STEROID HORMONES.
A transcription factor that takes part in WNT signaling pathway. The activity of the protein is regulated via its interaction with BETA CATENIN. Transcription factor 7-like 2 protein plays an important role in the embryogenesis of the PANCREAS and ISLET CELLS.
A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal.
A type of pancreatic cell representing about 5-20% of the islet cells. Alpha cells secrete GLUCAGON.
A noninvasive method for assessing BODY COMPOSITION. It is based on the differential absorption of X-RAYS (or GAMMA RAYS) by different tissues such as bone, fat and other soft tissues. The source of (X-ray or gamma-ray) photon beam is generated either from radioisotopes such as GADOLINIUM 153, IODINE 125, or Americanium 241 which emit GAMMA RAYS in the appropriate range; or from an X-ray tube which produces X-RAYS in the desired range. It is primarily used for quantitating BONE MINERAL CONTENT, especially for the diagnosis of OSTEOPOROSIS, and also in measuring BONE MINERALIZATION.
Fatty tissue under the SKIN through out the body.
A state of insufficient flesh on the body usually defined as having a body weight less than skeletal and physical standards. Depending on age, sex, and genetic background, a BODY MASS INDEX of less than 18.5 is considered as underweight.
A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
VASCULAR DISEASES that are associated with DIABETES MELLITUS.
Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.

Neurosurgery restores late GH rise after glucose-induced suppression in cured acromegalics. (1/4435)

OBJECTIVE AND DESIGN: A decrease of GH levels below 2 microg/l after an oral glucose tolerance test (OGTT) is still currently accepted as the gold standard for assessing cure in surgically treated acromegaly. Whether glucose-induced suppression of GH is accompanied by a restoration of normal GH late rebound has not yet been evaluated in this disease. In order to assess the restoration of normal GH regulation after removal of a pituitary adenoma, we have evaluated GH changes after an OGTT in a series of selected acromegalic patients (transsphenoidal surgery and lack of pituitary failure). METHODS: Twenty-nine patients (13 male, 16 female, age range 27-70 years) entered the study. Their neuroradiological imaging before neurosurgery showed microadenoma in 7, intrasellar macroadenoma in 8 and macroadenoma with extrasellar extension in 14. Plasma GH levels were assayed up to 300 min after glucose administration (75 g p.o.) and IGF-I on basal samples. RESULTS: Basal GH levels were below 5 microg/l in 20 patients and below 2 microg/l in 5 of these. Normal age-adjusted IGF-I levels were observed in 12 patients. GH values were suppressed below 2 microg/l during an OGTT in 13 patients, and below 1 microg/l in 7 of these. In 9 patients out of these 13, a marked rise in GH levels occurred after nadir. Baseline and nadir GH values of these 9 patients were not different from the corresponding values of the other 4 patients without OGTT-induced late GH peaks. CONCLUSIONS: GH rebound after GH nadir occurs in acromegalic patients considered as cured on the basis of OGTT-induced GH suppression and/or IGF-I normalization. The restoration of this physiological response could be regarded as a marker of recovered/preserved integrity of the hypothalamic-pituitary axis. Even though the reason for this GH rebound has not yet been elucidated (GHRH discharge?/end of somatostatin inhibition?), the lack of late GH peak in the patients regarded as cured by the usual criteria could be due to injury to the pituitary stalk caused by the adenoma or by surgical manipulation.  (+info)

No association between the -308 polymorphism in the tumour necrosis factor alpha (TNFalpha) promoter region and polycystic ovaries. (2/4435)

The tumour necrosis factor (TNF)2 allele appears to be linked with increased insulin resistance and obesity, conditions often found in overweight patients with polycystic ovary syndrome (PCOS). The significance of TNFalpha polymorphism in relation to the clinical and biochemical parameters associated with PCOS was investigated in 122 well-characterized patients with polycystic ovaries (PCO). Of these, 84 had an abnormal menstrual cycle and were classified as having PCOS, while the remaining 38 had a normal menstrual cycle and were classified as having PCO. There were a further 28 individuals without PCO (non-PCO) and 108 individuals whose PCO status was undetermined (reference population). The promoter region of the TNFalpha gene was amplified by polymerase chain reaction (PCR), and the presence or absence of the polymorphism at -308 was determined by single-strand conformational polymorphism (SSCP) analysis. The less common TNF allele (TNF2) was found as TNF1/2 or TNF2/2 in 11/38 (29%) of PCO subjects, 25/84 (30%) of PCOS subjects, 7/28 (25%) of non-PCO subjects, and 45/108 (42%) of the reference population. There was no significant difference in the incidence of the TNF2 allele between the groups. The relationship of TNF genotype to clinical and biochemical parameters was examined. In both the PCO group and the PCOS group, the presence of the TNF2 allele was significantly associated with lower glucose values obtained from the glucose tolerance testing (P<0.05). The TNF genotype was not significantly associated with any clinical or biochemical parameter measured in the PCO, PCOS or non-PCOS groups. Thus, the TNFalpha -308 polymorphism does not appear to strongly influence genetic susceptibility to polycystic ovaries.  (+info)

Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. (3/4435)

We are conducting a genome scan at an average resolution of 10 centimorgans (cM) for type 2 diabetes susceptibility genes in 716 affected sib pairs from 477 Finnish families. To date, our best evidence for linkage is on chromosome 20 with potentially separable peaks located on both the long and short arms. The unweighted multipoint maximum logarithm of odds score (MLS) was 3.08 on 20p (location, chi = 19.5 cM) under an additive model, whereas the weighted MLS was 2.06 on 20q (chi = 57 cM, recurrence risk,lambda(s) = 1. 25, P = 0.009). Weighted logarithm of odds scores of 2.00 (chi = 69.5 cM, P = 0.010) and 1.92 (chi = 18.5 cM, P = 0.013) were also observed. Ordered subset analyses based on sibships with extreme mean values of diabetes-related quantitative traits yielded sets of families who contributed disproportionately to the peaks. Two-hour glucose levels in offspring of diabetic individuals gave a MLS of 2. 12 (P = 0.0018) at 9.5 cM. Evidence from this and other studies suggests at least two diabetes-susceptibility genes on chromosome 20. We have also screened the gene for maturity-onset diabetes of the young 1, hepatic nuclear factor 4-a (HNF-4alpha) in 64 affected sibships with evidence for high chromosomal sharing at its location on chromosome 20q. We found no evidence that sequence changes in this gene accounted for the linkage results we observed.  (+info)

Training in swimming reduces blood pressure and increases muscle glucose transport activity as well as GLUT4 contents in stroke-prone spontaneously hypertensive rats. (4/4435)

Exercise improves muscle insulin sensitivity and GLUT4 contents. We investigated the beneficial effects of swimming training on insulin sensitivity and genetic hypertension using stroke-prone hypertensive rats (SHRSP). We studied the relationship between genetic hypertension and insulin resistance in SHRSP and Wistar Kyoto rats (WKY) as a control. The systolic blood pressure of SHRSP was significantly reduced by 4-week swimming training (208.4 +/- 6.8 mmHg vs. 187.2 +/- 4.1 mmHg, p < 0.05). The swimming training also resulted in an approximately 20% increase in the insulin-stimulated glucose transport activity (p < 0.05) of soleus muscle strips and an approximately 3-fold increase in the plasma membrane GLUT4 protein expression (p < 0.01) in SHRSP. However, basal and insulin-stimulated glucose transport activity and GLUT4 contents were not significantly different between WKY and SHRSP. There was no difference in insulin resistance in skeletal muscle of SHRSP as compared with WKY. Our results indicated swimming training exercise improved not only hypertension but also muscle insulin sensitivity and GLUT4 protein expression in SHRSP.  (+info)

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. (5/4435)

Protein tyrosine phosphatase-1B (PTP-1B) has been implicated in the negative regulation of insulin signaling. Disruption of the mouse homolog of the gene encoding PTP-1B yielded healthy mice that, in the fed state, had blood glucose concentrations that were slightly lower and concentrations of circulating insulin that were one-half those of their PTP-1B+/+ littermates. The enhanced insulin sensitivity of the PTP-1B-/- mice was also evident in glucose and insulin tolerance tests. The PTP-1B-/- mice showed increased phosphorylation of the insulin receptor in liver and muscle tissue after insulin injection in comparison to PTP-1B+/+ mice. On a high-fat diet, the PTP-1B-/- and PTP-1B+/- mice were resistant to weight gain and remained insulin sensitive, whereas the PTP-1B+/+ mice rapidly gained weight and became insulin resistant. These results demonstrate that PTP-1B has a major role in modulating both insulin sensitivity and fuel metabolism, thereby establishing it as a potential therapeutic target in the treatment of type 2 diabetes and obesity.  (+info)

Resistance training affects GLUT-4 content in skeletal muscle of humans after 19 days of head-down bed rest. (6/4435)

This study assessed the effects of inactivity on GLUT-4 content of human skeletal muscle and evaluated resistance training as a countermeasure to inactivity-related changes in GLUT-4 content in skeletal muscle. Nine young men participated in the study. For 19 days, four control subjects remained in a -6 degrees head-down tilt at all times throughout bed rest, except for showering every other day. Five training group subjects also remained at bed rest, except during resistance training once in the morning. The resistance training consisted of 30 isometric maximal voluntary contractions for 3 s each; leg-press exercise was used to recruit the extensor muscles of the ankle, knee, and hip. Pauses (3 s) were allowed between bouts of maximal contraction. Muscle biopsy samples were obtained from the lateral aspect of vastus lateralis (VL) muscle before and after the bed rest. GLUT-4 content in VL muscle of the control group was significantly decreased after bed rest (473 +/- 48 vs. 398 +/- 66 counts. min-1. microgram membrane protein-1, before and after bed rest, respectively), whereas GLUT-4 significantly increased in the training group with bed rest (510 +/- 158 vs. 663 +/- 189 counts. min-1. microgram membrane protein-1, before and after bed rest, respectively). The present study demonstrated that GLUT-4 in VL muscle decreased by approximately 16% after 19 days of bed rest, and isometric resistance training during bed rest induced a 30% increase above the value of GLUT-4 before bed rest.  (+info)

Analysis of the relationship between fasting serum leptin levels and estimates of beta-cell function and insulin sensitivity in a population sample of 380 healthy young Caucasians. (7/4435)

OBJECTIVE: Circulating leptin levels correlate positively with the degree of obesity and prolonged hyperinsulinaemia increases serum leptin levels. Moreover, insulin secreting beta-cells express functional leptin receptors indicating a functional relationship between leptin and insulin. The aim of this study was to examine the relationship between fasting serum leptin levels and measures of insulin sensitivity and beta-cell function in a population-based sample of 380 young healthy Caucasians. DESIGN AND METHODS: Multiple regression analysis was employed to analyse the relationship between fasting serum leptin levels and levels of fasting serum insulin, insulin sensitivity index and acute insulin response (AIR) in a population-based study of 380 young healthy Caucasians who underwent a combined intravenous glucose and tolbutamide tolerance test. RESULTS AND CONCLUSION: Serum leptin levels were positively correlated to measures of adiposity and were 3.2 times higher in women than in men (P<0.00001). In multiple regression analyses adjusting for age, percentage body fat, waist circumference and maximal aerobic capacity, a significant positive correlation was observed between the fasting serum leptin concentrations and both fasting serum insulin levels (P<0.0001) and AIR (P = 0.014) for women. No significant interrelation of these variables was found in men. However, for both genders a significant negative correlation was observed between fasting serum leptin levels and measures of insulin sensitivity index (P = 0.007).  (+info)

Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). (8/4435)

Hyperinsulinemia is associated with the development of coronary heart disease. However, the underlying mechanisms are still poorly understood. Hypercoagulability and impaired fibrinolysis are possible candidates linking hyperinsulinism with atherosclerotic disease, and it has been suggested that proinsulin rather than insulin is the crucial pathophysiological agent. The aim of this study was to investigate the relationship of insulin and its precursors to markers of coagulation and fibrinolysis in a large triethnic population. A strong and independent relationship between plasminogen activator inhibitor-1 (PAI-1) antigen and insulin and its precursors (proinsulin, 32-33 split proinsulin) was found consistently across varying states of glucose tolerance (PAI-1 versus fasting insulin [proinsulin], r=0.38 [r=0.34] in normal glucose tolerance; r=0.42 [r=0.43] in impaired glucose tolerance; and r=0.38 [r=0.26] in type 2 diabetes; all P<0.001). The relationship remained highly significant even after accounting for insulin sensitivity as measured by a frequently sampled intravenous glucose tolerance test. In a stepwise multiple regression model after adjusting for age, sex, ethnicity, and clinic, both insulin and its precursors were significantly associated with PAI-1 levels. The relationship between fibrinogen and insulin and its precursors was significant in the overall population (r=0.20 for insulin and proinsulin; each P<0.001) but showed a more inconsistent pattern in subgroup analysis and after adjustments for demographic and metabolic variables. Stepwise multiple regression analysis showed that proinsulin (split products) but not fasting insulin significantly contributed to fibrinogen levels after adjustment for age, sex, clinic, and ethnicity. Decreased insulin sensitivity was independently associated with higher PAI-1 and fibrinogen levels. In summary, we were able to demonstrate an independent relationship of 2 crucial factors of hemostasis, fibrinogen and PAI-1, to insulin and its precursors. These findings may have important clinical implications in the risk assessment and prevention of macrovascular disease, not only in patients with overt diabetes but also in nondiabetic subjects who are hyperinsulinemic.  (+info)

1. Impaired glucose tolerance (IGT): This is a condition where the body has difficulty regulating blood sugar levels after consuming a meal.
2. Impaired fasting glucose (IFG): This is a condition where the body has difficulty regulating blood sugar levels when fasting (not eating for a period of time).
3. Gestational diabetes: This is a type of diabetes that develops during pregnancy, usually in the second or third trimester.
4. Type 2 diabetes: This is a chronic condition where the body cannot effectively use insulin to regulate blood sugar levels.

The symptoms of glucose intolerance can vary depending on the type and severity of the condition. Some common symptoms include:

* High blood sugar levels
* Increased thirst and urination
* Fatigue
* Blurred vision
* Cuts or bruises that are slow to heal
* Tingling or numbness in the hands and feet

The diagnosis of glucose intolerance is typically made through a combination of physical examination, medical history, and laboratory tests such as:

* Fasting plasma glucose (FPG) test: This measures the level of glucose in the blood after an overnight fast.
* Oral glucose tolerance test (OGTT): This measures the body's ability to regulate blood sugar levels after consuming a sugary drink.
* Hemoglobin A1c (HbA1c) test: This measures the average blood sugar level over the past 2-3 months.

Treatment for glucose intolerance usually involves lifestyle changes such as:

* Eating a healthy, balanced diet that is low in added sugars and refined carbohydrates
* Increasing physical activity to help the body use insulin more effectively
* Losing weight if you are overweight or obese
* Monitoring blood sugar levels regularly

In some cases, medication may be prescribed to help manage blood sugar levels. These include:

* Metformin: This is a type of oral medication that helps the body use insulin more effectively.
* Sulfonylureas: These medications stimulate the release of insulin from the pancreas.
* Thiazolidinediones: These medications improve the body's sensitivity to insulin.

If left untreated, glucose intolerance can lead to a range of complications such as:

* Type 2 diabetes: This is a more severe form of glucose intolerance that can cause damage to the body's organs and tissues.
* Cardiovascular disease: High blood sugar levels can increase the risk of heart disease and stroke.
* Nerve damage: High blood sugar levels over an extended period can damage the nerves, leading to numbness, tingling, and pain in the hands and feet.
* Kidney damage: High blood sugar levels can damage the kidneys and lead to kidney disease.
* Eye damage: High blood sugar levels can damage the blood vessels in the eyes, leading to vision problems.

It is important to note that not everyone with glucose intolerance will develop these complications, but it is important to manage the condition to reduce the risk of these complications occurring.

There are several factors that can contribute to the development of insulin resistance, including:

1. Genetics: Insulin resistance can be inherited, and some people may be more prone to developing the condition based on their genetic makeup.
2. Obesity: Excess body fat, particularly around the abdominal area, can contribute to insulin resistance.
3. Physical inactivity: A sedentary lifestyle can lead to insulin resistance.
4. Poor diet: Consuming a diet high in refined carbohydrates and sugar can contribute to insulin resistance.
5. Other medical conditions: Certain medical conditions, such as polycystic ovary syndrome (PCOS) and Cushing's syndrome, can increase the risk of developing insulin resistance.
6. Medications: Certain medications, such as steroids and some antipsychotic drugs, can increase insulin resistance.
7. Hormonal imbalances: Hormonal changes during pregnancy or menopause can lead to insulin resistance.
8. Sleep apnea: Sleep apnea can contribute to insulin resistance.
9. Chronic stress: Chronic stress can lead to insulin resistance.
10. Aging: Insulin resistance tends to increase with age, particularly after the age of 45.

There are several ways to diagnose insulin resistance, including:

1. Fasting blood sugar test: This test measures the level of glucose in the blood after an overnight fast.
2. Glucose tolerance test: This test measures the body's ability to regulate blood sugar levels after consuming a sugary drink.
3. Insulin sensitivity test: This test measures the body's ability to respond to insulin.
4. Homeostatic model assessment (HOMA): This is a mathematical formula that uses the results of a fasting glucose and insulin test to estimate insulin resistance.
5. Adiponectin test: This test measures the level of adiponectin, a protein produced by fat cells that helps regulate blood sugar levels. Low levels of adiponectin are associated with insulin resistance.

There is no cure for insulin resistance, but it can be managed through lifestyle changes and medication. Lifestyle changes include:

1. Diet: A healthy diet that is low in processed carbohydrates and added sugars can help improve insulin sensitivity.
2. Exercise: Regular physical activity, such as aerobic exercise and strength training, can improve insulin sensitivity.
3. Weight loss: Losing weight, particularly around the abdominal area, can improve insulin sensitivity.
4. Stress management: Strategies to manage stress, such as meditation or yoga, can help improve insulin sensitivity.
5. Sleep: Getting adequate sleep is important for maintaining healthy insulin levels.

Medications that may be used to treat insulin resistance include:

1. Metformin: This is a commonly used medication to treat type 2 diabetes and improve insulin sensitivity.
2. Thiazolidinediones (TZDs): These medications, such as pioglitazone, improve insulin sensitivity by increasing the body's ability to use insulin.
3. Sulfonylureas: These medications stimulate the release of insulin from the pancreas, which can help improve insulin sensitivity.
4. DPP-4 inhibitors: These medications, such as sitagliptin, work by reducing the breakdown of the hormone incretin, which helps to increase insulin secretion and improve insulin sensitivity.
5. GLP-1 receptor agonists: These medications, such as exenatide, mimic the action of the hormone GLP-1 and help to improve insulin sensitivity.

It is important to note that these medications may have side effects, so it is important to discuss the potential benefits and risks with your healthcare provider before starting treatment. Additionally, lifestyle modifications such as diet and exercise can also be effective in improving insulin sensitivity and managing blood sugar levels.

Type 2 diabetes can be managed through a combination of diet, exercise, and medication. In some cases, lifestyle changes may be enough to control blood sugar levels, while in other cases, medication or insulin therapy may be necessary. Regular monitoring of blood sugar levels and follow-up with a healthcare provider are important for managing the condition and preventing complications.

Common symptoms of type 2 diabetes include:

* Increased thirst and urination
* Fatigue
* Blurred vision
* Cuts or bruises that are slow to heal
* Tingling or numbness in the hands and feet
* Recurring skin, gum, or bladder infections

If left untreated, type 2 diabetes can lead to a range of complications, including:

* Heart disease and stroke
* Kidney damage and failure
* Nerve damage and pain
* Eye damage and blindness
* Foot damage and amputation

The exact cause of type 2 diabetes is not known, but it is believed to be linked to a combination of genetic and lifestyle factors, such as:

* Obesity and excess body weight
* Lack of physical activity
* Poor diet and nutrition
* Age and family history
* Certain ethnicities (e.g., African American, Hispanic/Latino, Native American)
* History of gestational diabetes or delivering a baby over 9 lbs.

There is no cure for type 2 diabetes, but it can be managed and controlled through a combination of lifestyle changes and medication. With proper treatment and self-care, people with type 2 diabetes can lead long, healthy lives.

The American Diabetes Association (ADA) defines prediabetes as having a fasting blood sugar level of 100-125 mg/dL or a 2-hour postprandial (after meal) blood sugar level of 140-199 mg/dL.

The prediabetic state is characterized by insulin resistance, which means that the body's cells are not able to effectively use insulin, a hormone produced by the pancreas that regulates blood sugar levels. As a result, blood sugar levels begin to rise, but not high enough to be classified as diabetes.

Prediabetes is a reversible condition, and individuals with this condition can take steps to lower their blood sugar levels and prevent the development of type 2 diabetes. Lifestyle changes such as losing weight, increasing physical activity, and following a healthy diet can help improve insulin sensitivity and reduce the risk of developing diabetes. In some cases, medication may also be prescribed to help lower blood sugar levels.

It's important to note that not everyone with prediabetes will develop type 2 diabetes, but it is a significant risk factor. Early detection and intervention can help prevent or delay the progression to type 2 diabetes, and improve overall health outcomes.

Definition:

* A form of diabetes that develops during pregnancy
* Caused by hormonal changes and insulin resistance
* Can lead to complications for both the mother and the baby
* Typically goes away after childbirth

There are several types of diabetes mellitus, including:

1. Type 1 DM: This is an autoimmune condition in which the body's immune system attacks and destroys the cells in the pancreas that produce insulin, resulting in a complete deficiency of insulin production. It typically develops in childhood or adolescence, and patients with this condition require lifelong insulin therapy.
2. Type 2 DM: This is the most common form of diabetes, accounting for around 90% of all cases. It is caused by a combination of insulin resistance (where the body's cells do not respond properly to insulin) and impaired insulin secretion. It is often associated with obesity, physical inactivity, and a diet high in sugar and unhealthy fats.
3. Gestational DM: This type of diabetes develops during pregnancy, usually in the second or third trimester. Hormonal changes and insulin resistance can cause blood sugar levels to rise, putting both the mother and baby at risk.
4. LADA (Latent Autoimmune Diabetes in Adults): This is a form of type 1 DM that develops in adults, typically after the age of 30. It shares features with both type 1 and type 2 DM.
5. MODY (Maturity-Onset Diabetes of the Young): This is a rare form of diabetes caused by genetic mutations that affect insulin production. It typically develops in young adulthood and can be managed with lifestyle changes and/or medication.

The symptoms of diabetes mellitus can vary depending on the severity of the condition, but may include:

1. Increased thirst and urination
2. Fatigue
3. Blurred vision
4. Cuts or bruises that are slow to heal
5. Tingling or numbness in hands and feet
6. Recurring skin, gum, or bladder infections
7. Flu-like symptoms such as weakness, dizziness, and stomach pain
8. Dark, velvety skin patches (acanthosis nigricans)
9. Yellowish color of the skin and eyes (jaundice)
10. Delayed healing of cuts and wounds

If left untreated, diabetes mellitus can lead to a range of complications, including:

1. Heart disease and stroke
2. Kidney damage and failure
3. Nerve damage (neuropathy)
4. Eye damage (retinopathy)
5. Foot damage (neuropathic ulcers)
6. Cognitive impairment and dementia
7. Increased risk of infections and other diseases, such as pneumonia, gum disease, and urinary tract infections.

It is important to note that not all individuals with diabetes will experience these complications, and that proper management of the condition can greatly reduce the risk of developing these complications.

There are several different types of obesity, including:

1. Central obesity: This type of obesity is characterized by excess fat around the waistline, which can increase the risk of health problems such as type 2 diabetes and cardiovascular disease.
2. Peripheral obesity: This type of obesity is characterized by excess fat in the hips, thighs, and arms.
3. Visceral obesity: This type of obesity is characterized by excess fat around the internal organs in the abdominal cavity.
4. Mixed obesity: This type of obesity is characterized by both central and peripheral obesity.

Obesity can be caused by a variety of factors, including genetics, lack of physical activity, poor diet, sleep deprivation, and certain medications. Treatment for obesity typically involves a combination of lifestyle changes, such as increased physical activity and a healthy diet, and in some cases, medication or surgery may be necessary to achieve weight loss.

Preventing obesity is important for overall health and well-being, and can be achieved through a variety of strategies, including:

1. Eating a healthy, balanced diet that is low in added sugars, saturated fats, and refined carbohydrates.
2. Engaging in regular physical activity, such as walking, jogging, or swimming.
3. Getting enough sleep each night.
4. Managing stress levels through relaxation techniques, such as meditation or deep breathing.
5. Avoiding excessive alcohol consumption and quitting smoking.
6. Monitoring weight and body mass index (BMI) on a regular basis to identify any changes or potential health risks.
7. Seeking professional help from a healthcare provider or registered dietitian for personalized guidance on weight management and healthy lifestyle choices.

There are several possible causes of hyperglycemia, including:

1. Diabetes: This is a chronic condition where the body either does not produce enough insulin or cannot use insulin effectively.
2. Insulin resistance: This occurs when the body's cells become less responsive to insulin, leading to high blood sugar levels.
3. Pancreatitis: This is inflammation of the pancreas, which can lead to high blood sugar levels.
4. Cushing's syndrome: This is a rare hormonal disorder that can cause high blood sugar levels.
5. Medications: Certain medications, such as steroids and some types of antidepressants, can raise blood sugar levels.
6. Stress: Stress can cause the release of hormones such as cortisol and adrenaline, which can raise blood sugar levels.
7. Infections: Certain infections, such as pneumonia or urinary tract infections, can cause high blood sugar levels.
8. Trauma: Traumatic injuries can cause high blood sugar levels due to the release of stress hormones.
9. Surgery: Some types of surgery, such as heart bypass surgery, can cause high blood sugar levels.
10. Pregnancy: High blood sugar levels can occur during pregnancy, especially in women who have a history of gestational diabetes.

Hyperglycemia can cause a range of symptoms, including:

1. Increased thirst and urination
2. Fatigue
3. Blurred vision
4. Headaches
5. Cuts or bruises that are slow to heal
6. Tingling or numbness in the hands and feet
7. Dry, itchy skin
8. Flu-like symptoms, such as weakness, dizziness, and stomach pain
9. Recurring skin, gum, or bladder infections
10. Sexual dysfunction in men and women

If left untreated, hyperglycemia can lead to serious complications, including:

1. Diabetic ketoacidosis (DKA): A life-threatening condition that occurs when the body produces high levels of ketones, which are acidic substances that can cause confusion, nausea, and vomiting.
2. Hypoglycemia: Low blood sugar levels that can cause dizziness, confusion, and even loss of consciousness.
3. Nerve damage: High blood sugar levels over an extended period can damage the nerves, leading to numbness, tingling, and pain in the hands and feet.
4. Kidney damage: The kidneys may become overworked and damaged if they are unable to filter out the excess glucose in the blood.
5. Eye damage: High blood sugar levels can cause damage to the blood vessels in the eyes, leading to vision loss and blindness.
6. Cardiovascular disease: Hyperglycemia can increase the risk of cardiovascular disease, including heart attacks, strokes, and peripheral artery disease.
7. Cognitive impairment: Hyperglycemia has been linked to cognitive impairment and an increased risk of dementia.

It is essential to manage hyperglycemia by making lifestyle changes, such as following a healthy diet, regular exercise, and taking medication if prescribed by a healthcare professional. Monitoring blood sugar levels regularly can help identify the signs of hyperglycemia and prevent long-term complications.

Some common types of glucose metabolism disorders include:

1. Diabetes mellitus: This is a group of diseases characterized by high blood sugar levels due to defects in insulin production, insulin action, or both. There are several types of diabetes, including type 1, type 2, and gestational diabetes.
2. Hypoglycemia: This is a condition characterized by low blood sugar levels, typically below 70 mg/dL. It can be caused by a variety of factors, including medication side effects, hormonal changes, or certain medical conditions.
3. Hyperglycemia: This is a condition characterized by high blood sugar levels, typically above 140 mg/dL. It can be caused by a variety of factors, including diabetes, stress, or medication side effects.
4. Insulin resistance: This is a condition in which the body's cells become less responsive to insulin, leading to high blood sugar levels. It is often associated with type 2 diabetes and obesity.
5. Metabolic syndrome: This is a cluster of conditions that increase the risk of developing type 2 diabetes and cardiovascular disease. These conditions include central obesity, hypertension, high triglycerides, low HDL cholesterol, and high blood sugar.

Glucose metabolism disorders can have serious complications if left untreated, including nerve damage, kidney damage, and an increased risk of heart disease and stroke. Treatment for these disorders typically involves a combination of dietary changes, medication, and lifestyle modifications.

In hyperinsulinism, the body produces too much insulin, leading to a range of symptoms including:

1. Hypoglycemia (low blood sugar): Excessive insulin can cause blood sugar levels to drop too low, leading to hypoglycemic symptoms such as shakiness, dizziness, confusion, and rapid heartbeat.
2. Weight gain: Hyperinsulinism can lead to weight gain due to the body's inability to effectively use glucose for energy production.
3. Fatigue: Excessive insulin can cause fatigue, as the body's cells are not able to effectively use glucose for energy production.
4. Mood changes: Hyperinsulinism can lead to mood changes such as irritability, anxiety, and depression.
5. Polycystic ovary syndrome (PCOS): Women with PCOS are at a higher risk of developing hyperinsulinism due to insulin resistance.
6. Gestational diabetes: Hyperinsulinism can occur during pregnancy, leading to gestational diabetes.
7. Acanthosis nigricans: A condition characterized by dark, velvety patches on the skin, often found in the armpits, neck, and groin area.
8. Cancer: Hyperinsulinism has been linked to an increased risk of certain types of cancer, such as breast, colon, and pancreatic cancer.
9. Cardiovascular disease: Excessive insulin can increase the risk of cardiovascular disease, including high blood pressure, heart disease, and stroke.
10. Cognitive impairment: Hyperinsulinism has been linked to cognitive impairment and an increased risk of dementia.

There are several causes of hyperinsulinism, including:

1. Insulin-producing tumors: Tumors that produce excessive amounts of insulin can lead to hyperinsulinism.
2. Familial hyperinsulinism: A genetic disorder that affects the regulation of insulin secretion and action.
3. Pancreatic beta-cell dysfunction: Dysfunction in the pancreatic beta cells, which produce insulin, can lead to hyperinsulinism.
4. Medications: Certain medications such as steroids and certain psychiatric drugs can cause hyperinsulinism.
5. Pituitary tumors: Tumors in the pituitary gland can lead to excessive secretion of growth hormone, which can stimulate insulin production.
6. Maternal diabetes during pregnancy: Women with diabetes during pregnancy may experience hyperinsulinism due to increased insulin resistance and higher insulin levels.
7. Gestational diabetes: High blood sugar during pregnancy can lead to hyperinsulinism.
8. Polycystic ovary syndrome (PCOS): Women with PCOS may experience hyperinsulinism due to insulin resistance and high insulin levels.
9. Cushing's syndrome: An endocrine disorder caused by excessive cortisol production can lead to hyperinsulinism.
10. Other medical conditions: Certain medical conditions such as thyroid disorders, adrenal gland disorders, and pituitary gland disorders can also cause hyperinsulinism.

It's important to note that some individuals with hyperinsulinism may not experience any symptoms, while others may experience a range of symptoms, including:

1. Weight gain
2. Fatigue
3. Headaches
4. Numbness or tingling in the hands and feet
5. Memory loss and difficulty concentrating
6. Mood changes, such as anxiety and depression
7. Skin problems, such as acne and thinning skin
8. Increased risk of heart disease and stroke
9. Growth retardation in children
10. Increased risk of developing type 2 diabetes

If you suspect that you or your child may have hyperinsulinism, it's important to consult with a healthcare professional for proper diagnosis and treatment. A doctor may perform a physical examination, take a medical history, and order blood tests to determine if hyperinsulinism is present and what may be causing it. Treatment options for hyperinsulinism will depend on the underlying cause of the condition. In some cases, medications such as metformin or other anti-diabetic drugs may be prescribed to help regulate blood sugar levels and reduce insulin production. In other cases, surgery or lifestyle changes may be necessary. With proper diagnosis and treatment, it is possible to manage hyperinsulinism and prevent or manage related health complications.

Body weight is an important health indicator, as it can affect an individual's risk for certain medical conditions, such as obesity, diabetes, and cardiovascular disease. Maintaining a healthy body weight is essential for overall health and well-being, and there are many ways to do so, including a balanced diet, regular exercise, and other lifestyle changes.

There are several ways to measure body weight, including:

1. Scale: This is the most common method of measuring body weight, and it involves standing on a scale that displays the individual's weight in kg or lb.
2. Body fat calipers: These are used to measure body fat percentage by pinching the skin at specific points on the body.
3. Skinfold measurements: This method involves measuring the thickness of the skin folds at specific points on the body to estimate body fat percentage.
4. Bioelectrical impedance analysis (BIA): This is a non-invasive method that uses electrical impulses to measure body fat percentage.
5. Dual-energy X-ray absorptiometry (DXA): This is a more accurate method of measuring body composition, including bone density and body fat percentage.

It's important to note that body weight can fluctuate throughout the day due to factors such as water retention, so it's best to measure body weight at the same time each day for the most accurate results. Additionally, it's important to use a reliable scale or measuring tool to ensure accurate measurements.

1. Irregular menstrual cycles, or amenorrhea (the absence of periods).
2. Cysts on the ovaries, which are fluid-filled sacs that can be detected by ultrasound.
3. Elevated levels of androgens (male hormones) in the body, which can cause a range of symptoms including acne, excessive hair growth, and male pattern baldness.
4. Insulin resistance, which is a condition in which the body's cells do not respond properly to insulin, leading to high blood sugar levels.

PCOS is a complex disorder, and there is no single cause. However, genetics, hormonal imbalances, and insulin resistance are thought to play a role in its development. It is estimated that 5-10% of women of childbearing age have PCOS, making it one of the most common endocrine disorders affecting women.

There are several symptoms of PCOS, including:

1. Irregular menstrual cycles or amenorrhea
2. Weight gain or obesity
3. Acne
4. Excessive hair growth on the face, chest, and back
5. Male pattern baldness
6. Infertility or difficulty getting pregnant
7. Mood changes, such as depression and anxiety
8. Sleep apnea

PCOS can be diagnosed through a combination of physical examination, medical history, and laboratory tests, including:

1. Pelvic exam: A doctor will examine the ovaries and uterus to look for cysts or other abnormalities.
2. Ultrasound: An ultrasound can be used to detect cysts on the ovaries and to evaluate the thickness of the uterine lining.
3. Hormone testing: Blood tests can be used to measure levels of androgens, estrogen, and progesterone.
4. Glucose tolerance test: This test is used to check for insulin resistance, which is a common finding in women with PCOS.
5. Laparoscopy: A small camera inserted through a small incision in the abdomen can be used to visualize the ovaries and uterus and to diagnose PCOS.

There is no cure for PCOS, but it can be managed with lifestyle changes and medication. Treatment options include:

1. Weight loss: Losing weight can improve insulin sensitivity and reduce androgen levels.
2. Hormonal birth control: Birth control pills or other hormonal contraceptives can help regulate menstrual cycles and reduce androgen levels.
3. Fertility medications: Clomiphene citrate and letrozole are commonly used to stimulate ovulation in women with PCOS.
4. Injectable fertility medications: Gonadotropins, such as follicle-stimulating hormone (FSH) and luteinizing hormone (LH), can be used to stimulate ovulation.
5. Surgery: Laparoscopic ovarian drilling or laser surgery can improve ovulation and fertility in women with PCOS.
6. Assisted reproductive technology (ART): In vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) can be used to help women with PCOS conceive.
7. Alternative therapies: Some complementary and alternative therapies, such as acupuncture and herbal supplements, may be helpful in managing symptoms of PCOS.

It is important for women with PCOS to work closely with their healthcare provider to develop a treatment plan that meets their individual needs and goals. With appropriate treatment, many women with PCOS can improve their menstrual regularity, fertility, and overall health.

The word "acromegaly" comes from the Greek words "akros," meaning "tip" or " extremity," and "megas," meaning "large." It was first used in the medical literature in the late 19th century to describe the condition.

Symptoms of acromegaly can include:

* Enlarged hands and feet
* Coarsening of facial features
* Joint pain and limited joint mobility
* Carpal tunnel syndrome
* Sleep apnea
* Vision problems
* Fatigue
* Weakness

If left untreated, acromegaly can lead to serious complications such as diabetes, hypertension, and cardiovascular disease. Treatment options for acromegaly include surgery to remove the pituitary tumor, radiation therapy, and medications to reduce GH production.

It's worth noting that acromegaly is different from gigantism, which is a condition where children experience excessive growth and height due to an overproduction of growth hormone during childhood. Acromegaly only occurs in adults and is typically caused by a benign tumor on the pituitary gland, while gigantism can be caused by a variety of factors, including genetics, brain injuries, and certain medical conditions.

Types of Experimental Diabetes Mellitus include:

1. Streptozotocin-induced diabetes: This type of EDM is caused by administration of streptozotocin, a chemical that damages the insulin-producing beta cells in the pancreas, leading to high blood sugar levels.
2. Alloxan-induced diabetes: This type of EDM is caused by administration of alloxan, a chemical that also damages the insulin-producing beta cells in the pancreas.
3. Pancreatectomy-induced diabetes: In this type of EDM, the pancreas is surgically removed or damaged, leading to loss of insulin production and high blood sugar levels.

Experimental Diabetes Mellitus has several applications in research, including:

1. Testing new drugs and therapies for diabetes treatment: EDM allows researchers to evaluate the effectiveness of new treatments on blood sugar control and other physiological processes.
2. Studying the pathophysiology of diabetes: By inducing EDM in animals, researchers can study the progression of diabetes and its effects on various organs and tissues.
3. Investigating the role of genetics in diabetes: Researchers can use EDM to study the effects of genetic mutations on diabetes development and progression.
4. Evaluating the efficacy of new diagnostic techniques: EDM allows researchers to test new methods for diagnosing diabetes and monitoring blood sugar levels.
5. Investigating the complications of diabetes: By inducing EDM in animals, researchers can study the development of complications such as retinopathy, nephropathy, and cardiovascular disease.

In conclusion, Experimental Diabetes Mellitus is a valuable tool for researchers studying diabetes and its complications. The technique allows for precise control over blood sugar levels and has numerous applications in testing new treatments, studying the pathophysiology of diabetes, investigating the role of genetics, evaluating new diagnostic techniques, and investigating complications.

1. Abdominal obesity (excess fat around the waistline)
2. High blood pressure (hypertension)
3. Elevated fasting glucose (high blood sugar)
4. High serum triglycerides (elevated levels of triglycerides in the blood)
5. Low HDL cholesterol (low levels of "good" cholesterol)

Having three or more of these conditions is considered a diagnosis of metabolic syndrome X. It is estimated that approximately 34% of adults in the United States have this syndrome, and it is more common in women than men. Risk factors for developing metabolic syndrome include obesity, lack of physical activity, poor diet, and a family history of type 2 diabetes or CVD.

The term "metabolic syndrome" was first introduced in the medical literature in the late 1980s, and since then, it has been the subject of extensive research. The exact causes of metabolic syndrome are not yet fully understood, but it is believed to be related to insulin resistance, inflammation, and changes in body fat distribution.

Treatment for metabolic syndrome typically involves lifestyle modifications such as weight loss, regular physical activity, and a healthy diet. Medications such as blood pressure-lowering drugs, cholesterol-lowering drugs, and anti-diabetic medications may also be prescribed if necessary. It is important to note that not everyone with metabolic syndrome will develop type 2 diabetes or CVD, but the risk is increased. Therefore, early detection and treatment are crucial in preventing these complications.

In extreme cases, hypoglycemia can lead to seizures, loss of consciousness, and even coma. It is important to recognize the symptoms of hypoglycemia early on and seek medical attention if they persist or worsen over time. Treatment typically involves raising blood sugar levels through the consumption of quick-acting carbohydrates such as glucose tablets, fruit juice, or hard candy.

If left untreated, hypoglycemia can have serious consequences, including long-term damage to the brain, heart, and other organs. It is important for individuals with diabetes to monitor their blood sugar levels regularly and work with their healthcare provider to manage their condition effectively.

Symptoms of type 1 diabetes can include increased thirst and urination, blurred vision, fatigue, weight loss, and skin infections. If left untreated, type 1 diabetes can lead to serious complications such as kidney damage, nerve damage, and blindness.

Type 1 diabetes is diagnosed through a combination of physical examination, medical history, and laboratory tests such as blood glucose measurements and autoantibody tests. Treatment typically involves insulin therapy, which can be administered via injections or an insulin pump, as well as regular monitoring of blood glucose levels and appropriate lifestyle modifications such as a healthy diet and regular exercise.

1. Heart Disease: High blood sugar levels can damage the blood vessels and increase the risk of heart disease, which includes conditions like heart attacks, strokes, and peripheral artery disease.
2. Kidney Damage: Uncontrolled diabetes can damage the kidneys over time, leading to chronic kidney disease and potentially even kidney failure.
3. Nerve Damage: High blood sugar levels can damage the nerves in the body, causing numbness, tingling, and pain in the hands and feet. This is known as diabetic neuropathy.
4. Eye Problems: Diabetes can cause changes in the blood vessels of the eyes, leading to vision problems and even blindness. This is known as diabetic retinopathy.
5. Infections: People with diabetes are more prone to developing skin infections, urinary tract infections, and other types of infections due to their weakened immune system.
6. Amputations: Poor blood flow and nerve damage can lead to amputations of the feet or legs if left untreated.
7. Cognitive Decline: Diabetes has been linked to an increased risk of cognitive decline and dementia.
8. Sexual Dysfunction: Men with diabetes may experience erectile dysfunction, while women with diabetes may experience decreased sexual desire and vaginal dryness.
9. Gum Disease: People with diabetes are more prone to developing gum disease and other oral health problems due to their increased risk of infection.
10. Flu and Pneumonia: Diabetes can weaken the immune system, making it easier to catch the flu and pneumonia.

It is important for people with diabetes to manage their condition properly to prevent or delay these complications from occurring. This includes monitoring blood sugar levels regularly, taking medication as prescribed by a doctor, and following a healthy diet and exercise plan. Regular check-ups with a healthcare provider can also help identify any potential complications early on and prevent them from becoming more serious.

Being overweight can increase the risk of various health problems, such as heart disease, type 2 diabetes, high blood pressure, and certain types of cancer. It can also affect a person's mental health and overall quality of life.

There are several ways to assess whether someone is overweight or not. One common method is using the BMI, which is calculated based on height and weight. Another method is measuring body fat percentage, which can be done with specialized tools such as skinfold calipers or bioelectrical impedance analysis (BIA).

Losing weight and maintaining a healthy weight can be achieved through a combination of diet, exercise, and lifestyle changes. Some examples of healthy weight loss strategies include:

* Eating a balanced diet that is high in fruits, vegetables, whole grains, and lean protein sources
* Engaging in regular physical activity, such as walking, running, swimming, or weight training
* Avoiding fad diets and quick fixes
* Getting enough sleep and managing stress levels
* Setting realistic weight loss goals and tracking progress over time.

There are two main types of fatty liver disease:

1. Alcoholic fatty liver disease (AFLD): This type of fatty liver disease is caused by excessive alcohol consumption and is the most common cause of fatty liver disease in the United States.
2. Non-alcoholic fatty liver disease (NAFLD): This type of fatty liver disease is not caused by alcohol consumption and is the most common cause of fatty liver disease worldwide. It is often associated with obesity, diabetes, and high cholesterol.

There are several risk factors for developing fatty liver disease, including:

* Obesity
* Physical inactivity
* High calorie intake
* Alcohol consumption
* Diabetes
* High cholesterol
* High triglycerides
* History of liver disease

Symptoms of fatty liver disease can include:

* Fatigue
* Abdominal discomfort
* Loss of appetite
* Nausea and vomiting
* Abnormal liver function tests

Diagnosis of fatty liver disease is typically made through a combination of physical examination, medical history, and diagnostic tests such as:

* Liver biopsy
* Imaging studies (ultrasound, CT or MRI scans)
* Blood tests (lipid profile, glucose, insulin, and liver function tests)

Treatment of fatty liver disease depends on the underlying cause and severity of the condition. Lifestyle modifications such as weight loss, exercise, and a healthy diet can help improve the condition. In severe cases, medications such as antioxidants, fibric acids, and anti-inflammatory drugs may be prescribed. In some cases, surgery or other procedures may be necessary.

Prevention of fatty liver disease includes:

* Maintaining a healthy weight
* Eating a balanced diet low in sugar and saturated fats
* Engaging in regular physical activity
* Limiting alcohol consumption
* Managing underlying medical conditions such as diabetes and high cholesterol.

There are several different types of weight gain, including:

1. Clinical obesity: This is defined as a BMI of 30 or higher, and is typically associated with a range of serious health problems, such as heart disease, type 2 diabetes, and certain types of cancer.
2. Central obesity: This refers to excess fat around the waistline, which can increase the risk of health problems such as heart disease and type 2 diabetes.
3. Muscle gain: This occurs when an individual gains weight due to an increase in muscle mass, rather than fat. This type of weight gain is generally considered healthy and can improve overall fitness and athletic performance.
4. Fat gain: This occurs when an individual gains weight due to an increase in body fat, rather than muscle or bone density. Fat gain can increase the risk of health problems such as heart disease and type 2 diabetes.

Weight gain can be measured using a variety of methods, including:

1. Body mass index (BMI): This is a widely used measure of weight gain that compares an individual's weight to their height. A BMI of 18.5-24.9 is considered normal, while a BMI of 25-29.9 is considered overweight, and a BMI of 30 or higher is considered obese.
2. Waist circumference: This measures the distance around an individual's waistline and can be used to assess central obesity.
3. Skinfold measurements: These involve measuring the thickness of fat at specific points on the body, such as the abdomen or thighs.
4. Dual-energy X-ray absorptiometry (DXA): This is a non-invasive test that uses X-rays to measure bone density and body composition.
5. Bioelectrical impedance analysis (BIA): This is a non-invasive test that uses electrical impulses to measure body fat percentage and other physiological parameters.

Causes of weight gain:

1. Poor diet: Consuming high amounts of processed foods, sugar, and saturated fats can lead to weight gain.
2. Lack of physical activity: Engaging in regular exercise can help burn calories and maintain a healthy weight.
3. Genetics: An individual's genetic makeup can affect their metabolism and body composition, making them more prone to weight gain.
4. Hormonal imbalances: Imbalances in hormones such as insulin, thyroid, and cortisol can contribute to weight gain.
5. Medications: Certain medications, such as steroids and antidepressants, can cause weight gain as a side effect.
6. Sleep deprivation: Lack of sleep can disrupt hormones that regulate appetite and metabolism, leading to weight gain.
7. Stress: Chronic stress can lead to emotional eating and weight gain.
8. Age: Metabolism slows down with age, making it more difficult to maintain a healthy weight.
9. Medical conditions: Certain medical conditions such as hypothyroidism, Cushing's syndrome, and polycystic ovary syndrome (PCOS) can also contribute to weight gain.

Treatment options for obesity:

1. Lifestyle modifications: A combination of diet, exercise, and stress management techniques can help individuals achieve and maintain a healthy weight.
2. Medications: Prescription medications such as orlistat, phentermine-topiramate, and liraglutide can aid in weight loss.
3. Bariatric surgery: Surgical procedures such as gastric bypass surgery and sleeve gastrectomy can be effective for severe obesity.
4. Behavioral therapy: Cognitive-behavioral therapy (CBT) and other forms of counseling can help individuals develop healthy eating habits and improve their physical activity levels.
5. Meal replacement plans: Meal replacement plans such as Medifast can provide individuals with a structured diet that is high in protein, fiber, and vitamins, and low in calories and sugar.
6. Weight loss supplements: Supplements such as green tea extract, garcinia cambogia, and forskolin can help boost weight loss efforts.
7. Portion control: Using smaller plates and measuring cups can help individuals regulate their portion sizes and maintain a healthy weight.
8. Mindful eating: Paying attention to hunger and fullness cues, eating slowly, and savoring food can help individuals develop healthy eating habits.
9. Physical activity: Engaging in regular physical activity such as walking, running, swimming, or cycling can help individuals burn calories and maintain a healthy weight.

It's important to note that there is no one-size-fits-all approach to treating obesity, and the most effective treatment plan will depend on the individual's specific needs and circumstances. Consulting with a healthcare professional such as a registered dietitian or a physician can help individuals develop a personalized treatment plan that is safe and effective.

Pregnancy in diabetics is typically classified into three categories:

1. Gestational diabetes mellitus (GDM): This type of diabetes develops during pregnancy, typically after 24 weeks of gestation. It is caused by hormonal changes that interfere with insulin's ability to regulate blood sugar levels.
2. Pre-existing diabetes: Women who have already been diagnosed with diabetes before becoming pregnant are considered to have pre-existing diabetes. This type of diabetes can be either type 1 or type 2.
3. Type 1 diabetes in pregnancy: Type 1 diabetes is an autoimmune condition that typically develops in childhood or young adulthood. Women who have type 1 diabetes and become pregnant require careful management of their blood sugar levels to ensure the health of both themselves and their baby.

Pregnancy in diabetics requires close monitoring and careful management throughout the pregnancy. Regular check-ups with a healthcare provider are essential to identify any potential complications early on and prevent them from becoming more serious. Some of the common complications associated with pregnancy in diabetics include:

1. Gestational hypertension: This is a type of high blood pressure that develops during pregnancy, particularly in women who have gestational diabetes. It can increase the risk of preeclampsia and other complications.
2. Preeclampsia: This is a serious condition that can cause damage to organs such as the liver, kidneys, and brain. Women with pre-existing diabetes are at higher risk of developing preeclampsia.
3. Macrosomia: As mentioned earlier, this is a condition where the baby grows larger than average, which can increase the risk of complications during delivery.
4. Hypoglycemia: This is a condition where the blood sugar levels become too low, which can be dangerous for both the mother and the baby.
5. Jaundice: This is a condition that causes yellowing of the skin and eyes due to high bilirubin levels in the blood. It is more common in newborns of diabetic mothers.
6. Respiratory distress syndrome: This is a condition where the baby's lungs are not fully developed, which can lead to breathing difficulties.
7. Type 2 diabetes: Women who develop gestational diabetes during pregnancy are at higher risk of developing type 2 diabetes later in life.
8. Cholestasis of pregnancy: This is a condition where the liver produces too much bile, which can cause itching and liver damage. It is more common in women with gestational diabetes.
9. Premature birth: Babies born to mothers with diabetes are at higher risk of being born prematurely, which can increase the risk of complications.
10. Congenital anomalies: There is an increased risk of certain birth defects in babies born to mothers with diabetes, such as heart and brain defects.

It's important for pregnant women who have been diagnosed with gestational diabetes to work closely with their healthcare provider to manage their condition and reduce the risks associated with it. This may involve monitoring blood sugar levels regularly, taking insulin or other medications as prescribed, and making any necessary lifestyle changes.

There are two types of hypertension:

1. Primary Hypertension: This type of hypertension has no identifiable cause and is also known as essential hypertension. It accounts for about 90% of all cases of hypertension.
2. Secondary Hypertension: This type of hypertension is caused by an underlying medical condition or medication. It accounts for about 10% of all cases of hypertension.

Some common causes of secondary hypertension include:

* Kidney disease
* Adrenal gland disorders
* Hormonal imbalances
* Certain medications
* Sleep apnea
* Cocaine use

There are also several risk factors for hypertension, including:

* Age (the risk increases with age)
* Family history of hypertension
* Obesity
* Lack of exercise
* High sodium intake
* Low potassium intake
* Stress

Hypertension is often asymptomatic, and it can cause damage to the blood vessels and organs over time. Some potential complications of hypertension include:

* Heart disease (e.g., heart attacks, heart failure)
* Stroke
* Kidney disease (e.g., chronic kidney disease, end-stage renal disease)
* Vision loss (e.g., retinopathy)
* Peripheral artery disease

Hypertension is typically diagnosed through blood pressure readings taken over a period of time. Treatment for hypertension may include lifestyle changes (e.g., diet, exercise, stress management), medications, or a combination of both. The goal of treatment is to reduce the risk of complications and improve quality of life.

1) They share similarities with humans: Many animal species share similar biological and physiological characteristics with humans, making them useful for studying human diseases. For example, mice and rats are often used to study diseases such as diabetes, heart disease, and cancer because they have similar metabolic and cardiovascular systems to humans.

2) They can be genetically manipulated: Animal disease models can be genetically engineered to develop specific diseases or to model human genetic disorders. This allows researchers to study the progression of the disease and test potential treatments in a controlled environment.

3) They can be used to test drugs and therapies: Before new drugs or therapies are tested in humans, they are often first tested in animal models of disease. This allows researchers to assess the safety and efficacy of the treatment before moving on to human clinical trials.

4) They can provide insights into disease mechanisms: Studying disease models in animals can provide valuable insights into the underlying mechanisms of a particular disease. This information can then be used to develop new treatments or improve existing ones.

5) Reduces the need for human testing: Using animal disease models reduces the need for human testing, which can be time-consuming, expensive, and ethically challenging. However, it is important to note that animal models are not perfect substitutes for human subjects, and results obtained from animal studies may not always translate to humans.

6) They can be used to study infectious diseases: Animal disease models can be used to study infectious diseases such as HIV, TB, and malaria. These models allow researchers to understand how the disease is transmitted, how it progresses, and how it responds to treatment.

7) They can be used to study complex diseases: Animal disease models can be used to study complex diseases such as cancer, diabetes, and heart disease. These models allow researchers to understand the underlying mechanisms of the disease and test potential treatments.

8) They are cost-effective: Animal disease models are often less expensive than human clinical trials, making them a cost-effective way to conduct research.

9) They can be used to study drug delivery: Animal disease models can be used to study drug delivery and pharmacokinetics, which is important for developing new drugs and drug delivery systems.

10) They can be used to study aging: Animal disease models can be used to study the aging process and age-related diseases such as Alzheimer's and Parkinson's. This allows researchers to understand how aging contributes to disease and develop potential treatments.

There are several possible causes of hyperandrogenism, including:

1. Congenital adrenal hyperplasia (CAH): A genetic disorder that affects the production of cortisol and aldosterone hormones by the adrenal glands.
2. Polycystic ovary syndrome (PCOS): A hormonal disorder that affects women of reproductive age and is characterized by cysts on the ovaries, irregular menstrual cycles, and high levels of androgens.
3. Adrenal tumors: Tumors in the adrenal glands can cause excessive production of androgens.
4. Familial hyperandrogenism: A rare inherited condition that causes an overproduction of androgens.
5. Obesity: Excess body fat can lead to increased production of androgens.

The symptoms of hyperandrogenism can vary depending on the cause, but may include:

1. Acne
2. Hirsutism (excessive hair growth)
3. Virilization (male-like physical characteristics, such as deepening of the voice and clitoral enlargement in women)
4. Male pattern baldness
5. Increased muscle mass and strength
6. Irregular menstrual cycles or cessation of menstruation
7. Infertility
8. Elevated blood pressure
9. Elevated cholesterol levels

Treatment options for hyperandrogenism depend on the underlying cause, but may include:

1. Medications to reduce androgen production or block their effects
2. Hormone replacement therapy (HRT) to restore normal hormone balance
3. Surgery to remove tumors or cysts
4. Weight loss programs to reduce excess body fat
5. Lifestyle changes, such as exercise and dietary modifications, to improve overall health.

It's important to note that hyperandrogenism can also be caused by other factors, such as congenital adrenal hyperplasia or ovarian tumors, so it's important to consult a healthcare professional for proper diagnosis and treatment.

There are many different approaches to weight loss, and what works best for one person may not work for another. Some common strategies for weight loss include:

* Caloric restriction: Reducing daily caloric intake to create a calorie deficit that promotes weight loss.
* Portion control: Eating smaller amounts of food and avoiding overeating.
* Increased physical activity: Engaging in regular exercise, such as walking, running, swimming, or weightlifting, to burn more calories and build muscle mass.
* Behavioral modifications: Changing habits and behaviors related to eating and exercise, such as keeping a food diary or enlisting the support of a weight loss buddy.

Weight loss can have numerous health benefits, including:

* Improved blood sugar control
* Reduced risk of heart disease and stroke
* Lowered blood pressure
* Improved joint health and reduced risk of osteoarthritis
* Improved sleep quality
* Boosted mood and reduced stress levels
* Increased energy levels

However, weight loss can also be challenging, and it is important to approach it in a healthy and sustainable way. Crash diets and other extreme weight loss methods are not effective in the long term and can lead to nutrient deficiencies and other negative health consequences. Instead, it is important to focus on making sustainable lifestyle changes that can be maintained over time.

Some common misconceptions about weight loss include:

* All weight loss methods are effective for everyone.
* Weight loss should always be the primary goal of a fitness or health program.
* Crash diets and other extreme weight loss methods are a good way to lose weight quickly.
* Weight loss supplements and fad diets are a reliable way to achieve significant weight loss.

The most effective ways to lose weight and maintain weight loss include:

* Eating a healthy, balanced diet that is high in nutrient-dense foods such as fruits, vegetables, whole grains, lean proteins, and healthy fats.
* Engaging in regular physical activity, such as walking, running, swimming, or weight training.
* Getting enough sleep and managing stress levels.
* Aiming for a gradual weight loss of 1-2 pounds per week.
* Focusing on overall health and wellness rather than just the number on the scale.

It is important to remember that weight loss is not always linear and can vary from week to week. It is also important to be patient and consistent with your weight loss efforts, as it can take time to see significant results.

Overall, weight loss can be a challenging but rewarding process, and it is important to approach it in a healthy and sustainable way. By focusing on overall health and wellness rather than just the number on the scale, you can achieve a healthy weight and improve your overall quality of life.

1. Coronary artery disease: The narrowing or blockage of the coronary arteries, which supply blood to the heart.
2. Heart failure: A condition in which the heart is unable to pump enough blood to meet the body's needs.
3. Arrhythmias: Abnormal heart rhythms that can be too fast, too slow, or irregular.
4. Heart valve disease: Problems with the heart valves that control blood flow through the heart.
5. Heart muscle disease (cardiomyopathy): Disease of the heart muscle that can lead to heart failure.
6. Congenital heart disease: Defects in the heart's structure and function that are present at birth.
7. Peripheral artery disease: The narrowing or blockage of blood vessels that supply oxygen and nutrients to the arms, legs, and other organs.
8. Deep vein thrombosis (DVT): A blood clot that forms in a deep vein, usually in the leg.
9. Pulmonary embolism: A blockage in one of the arteries in the lungs, which can be caused by a blood clot or other debris.
10. Stroke: A condition in which there is a lack of oxygen to the brain due to a blockage or rupture of blood vessels.

Low birth weight is defined as less than 2500 grams (5 pounds 8 ounces) and is associated with a higher risk of health problems, including respiratory distress, infection, and developmental delays. Premature birth is also a risk factor for low birth weight, as premature infants may not have had enough time to grow to a healthy weight before delivery.

On the other hand, high birth weight is associated with an increased risk of macrosomia, a condition in which the baby is significantly larger than average and may require a cesarean section (C-section) or assisted delivery. Macrosomia can also increase the risk of injury to the mother during delivery.

Birth weight can be influenced by various factors during pregnancy, including maternal nutrition, prenatal care, and fetal growth patterns. However, it is important to note that birth weight alone is not a definitive indicator of a baby's health or future development. Other factors, such as the baby's overall physical condition, Apgar score (a measure of the baby's well-being at birth), and postnatal care, are also important indicators of long-term health outcomes.

Lactose intolerance is different from a milk allergy, which is an immune system reaction to milk proteins and can be life-threatening. Lactose intolerance is more common and typically affects adults of northern European ancestry, as they tend to have lower levels of lactase enzyme activity.

Symptoms of lactose intolerance typically occur within 30 minutes to 2 hours after consuming lactose-containing products and may include:

1. Bloating
2. Gas
3. Diarrhea
4. Stomach cramps
5. Nausea
6. Vomiting

If you suspect that you or someone else has lactose intolerance, it is important to speak with a healthcare professional for proper diagnosis and treatment. A healthcare professional may perform tests such as hydrogen breath tests or blood tests to determine the level of lactase enzyme activity in the body.

There is no cure for lactose intolerance, but individuals can manage their symptoms by limiting or avoiding lactose-containing products, taking lactase enzyme supplements, or using lactose-free alternatives. It is important to note that not all dairy products are high in lactose, and some may be better tolerated than others. For example, hard cheeses and yogurt contain less lactose than milk.

In summary, lactose intolerance is a common condition that affects individuals who have a deficiency of the enzyme lactase in their small intestine, leading to symptoms such as bloating, gas, diarrhea, and stomach cramps after consuming lactose-containing products. Proper diagnosis and management of lactose intolerance can help individuals manage their symptoms and improve their quality of life.

There are two main types of acanthosis nigricans:

1. Congenital acanthosis nigricans (CAN): present at birth and usually affects the neck, arms, and legs. This type is associated with certain genetic disorders such as Down syndrome.
2. Acquired acanthosis nigricans (AAN): develops over time and can occur in various parts of the body, particularly in areas exposed to the sun. It is often seen in people with obesity, diabetes, hypothyroidism, and other endocrine disorders.

The exact cause of acanthosis nigricans is not fully understood, but it is believed to be related to hormonal imbalances, insulin resistance, and inflammation. Treatment options include topical creams, phototherapy, and systemic medications such as retinoids and anti-diabetic drugs. In some cases, surgical excision may be necessary.

While acanthosis nigricans is not a life-threatening condition, it can have a significant impact on quality of life due to the unsightly appearance of the affected areas and potential skin irritation or infection. Early detection and proper management are essential to prevent complications and improve outcomes.

These diseases can cause a wide range of symptoms such as fatigue, weight changes, and poor wound healing. Treatment options vary depending on the specific condition but may include lifestyle changes, medications, or surgery.

Some common causes of fetal macrosomia include:

1. Gestational diabetes: High blood sugar levels during pregnancy can lead to excessive fetal growth, increasing the risk of macrosomia.
2. Obesity in pregnancy: Overweight or obese mothers are more likely to have larger babies due to increased insulin resistance and altered metabolism.
3. Fetal genetic disorders: Certain conditions such as Down syndrome or Turner syndrome can result in excessive fetal growth.
4. Maternal age: Elderly mothers (age 35+) may be more likely to have larger babies due to decreased egg quality and altered maternal metabolism.

Fetal macrosomia can increase the risk of complications during delivery, including:

1. Shoulder dystocia: This is a condition where the baby's shoulder becomes stuck in the mother's pelvis during delivery, which can lead to fractures or nerve damage.
2. Cesarean section: Macrosomic babies may require a cesarean section (C-section) due to their large size, which can increase the risk of complications for both mothers and babies.
3. Neonatal hypoglycemia: Newborns with macrosomia may experience low blood sugar levels due to excessive insulin production, which can lead to hypoglycemia (low blood sugar) and other complications.
4. Neonatal respiratory distress syndrome: Macrosomic babies may have underdeveloped lungs, leading to breathing difficulties and respiratory distress.

Specialized care and monitoring during pregnancy and childbirth can help manage the risks associated with fetal macrosomia. This may include:

1. Regular ultrasound measurements to monitor fetal growth and detect potential macrosomia early.
2. Close monitoring of maternal blood sugar levels and nutrition to ensure optimal fetal growth and development.
3. Planned deliveries in a hospital setting with experienced healthcare providers, including obstetricians and neonatologists.
4. Timely delivery if macrosomia is detected, either by C-section or vaginal delivery with the assistance of medical professionals.

If you have any concerns about your pregnancy or suspect that your baby may be experiencing fetal macrosomia, consult with your healthcare provider for proper evaluation and management.

Morbid obesity is typically defined as a BMI of 40 or higher, but some experts define it as a BMI of 35 or higher with one or more obesity-related health conditions, such as high blood pressure, type 2 diabetes, or sleep apnea.

Morbid obesity is different from simple obesity, which is defined as a BMI of 30 to 39. While simple obesity can also increase the risk of health problems, it is generally considered less severe than morbid obesity.

Morbid obesity is often treated with a combination of lifestyle changes, such as diet and exercise, and medications or surgery. In some cases, bariatric surgery may be recommended to help achieve and maintain weight loss.

It is important to note that BMI is not always an accurate measure of health, as it does not take into account muscle mass or body composition. However, it can provide a general indicator of whether an individual is at a healthy weight or if they are at risk for health problems due to their weight.

There are several types of hyperlipidemia, including:

1. High cholesterol: This is the most common type of hyperlipidemia and is characterized by elevated levels of low-density lipoprotein (LDL) cholesterol, also known as "bad" cholesterol.
2. High triglycerides: This type of hyperlipidemia is characterized by elevated levels of triglycerides in the blood. Triglycerides are a type of fat found in the blood that is used for energy.
3. Low high-density lipoprotein (HDL) cholesterol: HDL cholesterol is known as "good" cholesterol because it helps remove excess cholesterol from the bloodstream and transport it to the liver for excretion. Low levels of HDL cholesterol can contribute to hyperlipidemia.

Symptoms of hyperlipidemia may include xanthomas (fatty deposits on the skin), corneal arcus (a cloudy ring around the iris of the eye), and tendon xanthomas (tender lumps under the skin). However, many people with hyperlipidemia have no symptoms at all.

Hyperlipidemia can be diagnosed through a series of blood tests that measure the levels of different types of cholesterol and triglycerides in the blood. Treatment for hyperlipidemia typically involves dietary changes, such as reducing intake of saturated fats and cholesterol, and increasing physical activity. Medications such as statins, fibric acid derivatives, and bile acid sequestrants may also be prescribed to lower cholesterol levels.

In severe cases of hyperlipidemia, atherosclerosis (hardening of the arteries) can occur, which can lead to cardiovascular disease, including heart attacks and strokes. Therefore, it is important to diagnose and treat hyperlipidemia early on to prevent these complications.

There are several causes of hypertriglyceridemia, including:

* Genetics: Some people may inherit a tendency to have high triglyceride levels due to genetic mutations that affect the genes involved in triglyceride metabolism.
* Obesity: Excess body weight is associated with higher triglyceride levels, as there is more fat available for energy.
* Diabetes: Both type 1 and type 2 diabetes can lead to high triglyceride levels due to insulin resistance and altered glucose metabolism.
* High-carbohydrate diet: Consuming high amounts of carbohydrates, particularly refined or simple carbohydrates, can cause a spike in blood triglycerides.
* Alcohol consumption: Drinking too much alcohol can increase triglyceride levels in the blood.
* Certain medications: Some drugs, such as anabolic steroids and some antidepressants, can raise triglyceride levels.
* Underlying medical conditions: Certain medical conditions, such as hypothyroidism, kidney disease, and polycystic ovary syndrome (PCOS), can also contribute to high triglyceride levels.

Hypertriglyceridemia is typically diagnosed with a blood test that measures the level of triglycerides in the blood. Treatment options for hypertriglyceridemia depend on the underlying cause of the condition, but may include lifestyle modifications such as weight loss, dietary changes, and medications to lower triglyceride levels.

In medicine, thinness is sometimes used as a diagnostic criterion for certain conditions, such as anorexia nervosa or cancer cachexia. In these cases, thinness can be a sign of a serious underlying condition that requires medical attention.

However, it's important to note that thinness alone is not enough to diagnose any medical condition. Other factors, such as a person's overall health, medical history, and physical examination findings, must also be taken into account when making a diagnosis. Additionally, it's important to recognize that being underweight or having a low BMI does not necessarily mean that someone is unhealthy or has a medical condition. Many people with a healthy weight and body composition can still experience negative health effects from societal pressure to be thin.

Overall, the concept of thinness in medicine is complex and multifaceted, and it's important for healthcare providers to consider all relevant factors when evaluating a patient's weight and overall health.

There are several types of diabetic angiopathies, including:

1. Peripheral artery disease (PAD): This occurs when the blood vessels in the legs and arms become narrowed or blocked, leading to reduced blood flow and oxygen supply to the limbs.
2. Peripheral neuropathy: This is damage to the nerves in the hands and feet, which can cause pain, numbness, and weakness.
3. Retinopathy: This is damage to the blood vessels in the retina, which can lead to vision loss and blindness.
4. Nephropathy: This is damage to the kidneys, which can lead to kidney failure and the need for dialysis.
5. Cardiovascular disease: This includes heart attack, stroke, and other conditions that affect the heart and blood vessels.

The risk of developing diabetic angiopathies increases with the duration of diabetes and the level of blood sugar control. Other factors that can increase the risk include high blood pressure, high cholesterol, smoking, and a family history of diabetes-related complications.

Symptoms of diabetic angiopathies can vary depending on the specific type of complication and the location of the affected blood vessels or nerves. Common symptoms include:

* Pain or discomfort in the arms, legs, hands, or feet
* Numbness or tingling sensations in the hands and feet
* Weakness or fatigue in the limbs
* Difficulty healing wounds or cuts
* Vision changes or blindness
* Kidney problems or failure
* Heart attack or stroke

Diagnosis of diabetic angiopathies typically involves a combination of physical examination, medical history, and diagnostic tests such as ultrasound, MRI, or CT scans. Treatment options vary depending on the specific type of complication and may include:

* Medications to control blood sugar levels, high blood pressure, and high cholesterol
* Lifestyle changes such as a healthy diet and regular exercise
* Surgery to repair or bypass affected blood vessels or nerves
* Dialysis for kidney failure
* In some cases, amputation of the affected limb

Preventing diabetic angiopathies involves managing diabetes effectively through a combination of medication, lifestyle changes, and regular medical check-ups. Early detection and treatment can help prevent or delay the progression of complications.

Some of the symptoms of hirsutism include:

* Thick, dark hair on the face, chest, back, and buttocks
* Hair growth on the arms, legs, and other areas of the body
* Thinning or loss of hair on the head
* Acne and oily skin

Hirsutism can be caused by a variety of factors, including:

* Hormonal imbalances: Excessive levels of androgens, such as testosterone, can cause hirsutism.
* Genetics: Inheritance plays a role in the development of hirsutism.
* Medications: Certain medications, such as anabolic steroids and certain antidepressants, can cause hirsutism as a side effect.
* Other medical conditions: Polycystic ovary syndrome (PCOS), congenital adrenal hyperplasia (CAH), and other endocrine disorders can also cause hirsutism.

There are several treatment options for hirsutism, including:

* Medications such as anti-androgens and retinoids to reduce hair growth and improve skin texture
* Electrolysis and laser therapy to remove unwanted hair
* Hormonal therapies such as birth control pills and spironolactone to regulate hormone levels and reduce hair growth
* Plastic surgery to remove excess hair-bearing skin.

It is important for individuals with hirsutism to seek medical attention if they experience any of the following symptoms:

* Sudden or excessive hair growth
* Hair growth on the face, chest, back, or buttocks
* Thinning or loss of hair on the head
* Acne and oily skin.

Early diagnosis and treatment can help manage the symptoms of hirsutism and improve quality of life for individuals affected by this condition.

There are several ways to measure abdominal obesity, including:

1. Waist circumference: Measured by circling the natural waistline with a tape measure. Excess fat around the waistline is defined as a circumference of 35 inches or more for women and 40 inches or more for men.
2. Waist-to-hip ratio: Measured by dividing the circumference of the natural waistline by the circumference of the hips. A ratio of 0.8 or higher indicates abdominal obesity.
3. Body fat distribution: Measured using techniques such as dual-energy X-ray absorptiometry (DXA) or bioelectrical impedance analysis (BIA). These methods can estimate the amount of fat in various areas of the body, including the abdomen.

There are several factors that contribute to the development of abdominal obesity, including:

1. Genetics: Inheritance plays a role in the distribution of body fat, with some people more prone to accumulating fat around the midsection.
2. Poor diet: Consuming high amounts of processed foods, sugar, and saturated fats can contribute to weight gain and abdominal obesity.
3. Lack of physical activity: Sedentary lifestyle can lead to a decrease in muscle mass and an increase in body fat, including around the abdomen.
4. Age: As people age, their metabolism slows down, leading to weight gain and increased risk of obesity.
5. Hormonal imbalances: Certain hormonal imbalances, such as hypothyroidism or polycystic ovary syndrome (PCOS), can increase the risk of developing abdominal obesity.

Abdominal obesity is a significant health risk due to its association with various chronic diseases, including:

1. Type 2 diabetes: Excess fat around the abdominal area can lead to insulin resistance and increase the risk of developing type 2 diabetes.
2. Cardiovascular disease: Abdominal obesity is a major risk factor for heart disease, as excess fat in this area can increase the risk of high blood pressure, high cholesterol, and triglycerides.
3. Cancer: Studies have shown that central obesity is associated with an increased risk of certain types of cancer, including colon, breast, and pancreatic cancer.
4. Non-alcoholic fatty liver disease (NAFLD): Abdominal obesity can lead to the development of NAFLD, a condition characterized by fat accumulation in the liver, which can increase the risk of liver damage and other health complications.
5. Sleep apnea: Excess fat around the abdomen can increase the risk of sleep apnea, a condition characterized by pauses in breathing during sleep.
6. Respiratory problems: Abdominal obesity can increase the risk of respiratory problems, such as asthma and chronic obstructive pulmonary disease (COPD).
7. Osteoarthritis: Excess weight, particularly around the abdomen, can increase the risk of osteoarthritis in the knees and hips.
8. Mental health: Central obesity has been linked to an increased risk of depression and other mental health conditions.
9. Fertility problems: Abdominal obesity can affect fertility in both men and women, as excess fat can disrupt hormone levels and reduce the likelihood of conception.
10. Reduced life expectancy: Abdominal obesity is associated with a shorter life expectancy, as it increases the risk of various chronic diseases that can reduce lifespan.

Prenatal Exposure Delayed Effects can affect various aspects of the child's development, including:

1. Physical growth and development: PDEDs can lead to changes in the child's physical growth patterns, such as reduced birth weight, short stature, or delayed puberty.
2. Brain development: Prenatal exposure to certain substances can affect brain development, leading to learning disabilities, memory problems, and cognitive delays.
3. Behavioral and emotional development: Children exposed to PDEDs may exhibit behavioral and emotional difficulties, such as anxiety, depression, or attention deficit hyperactivity disorder (ADHD).
4. Immune system functioning: Prenatal exposure to certain substances can affect the immune system's development, making children more susceptible to infections and autoimmune diseases.
5. Reproductive health: Exposure to certain chemicals during fetal development may disrupt the reproductive system, leading to fertility problems or an increased risk of infertility later in life.

The diagnosis of Prenatal Exposure Delayed Effects often requires a comprehensive medical history and physical examination, as well as specialized tests such as imaging studies or laboratory assessments. Treatment for PDEDs typically involves addressing the underlying cause of exposure and providing appropriate interventions to manage any associated symptoms or developmental delays.

In summary, Prenatal Exposure Delayed Effects can have a profound impact on a child's growth, development, and overall health later in life. It is essential for healthcare providers to be aware of the potential risks and to monitor children exposed to substances during fetal development for any signs of PDEDs. With early diagnosis and appropriate interventions, it may be possible to mitigate or prevent some of these effects and improve outcomes for affected children.

There are several key features of inflammation:

1. Increased blood flow: Blood vessels in the affected area dilate, allowing more blood to flow into the tissue and bringing with it immune cells, nutrients, and other signaling molecules.
2. Leukocyte migration: White blood cells, such as neutrophils and monocytes, migrate towards the site of inflammation in response to chemical signals.
3. Release of mediators: Inflammatory mediators, such as cytokines and chemokines, are released by immune cells and other cells in the affected tissue. These molecules help to coordinate the immune response and attract more immune cells to the site of inflammation.
4. Activation of immune cells: Immune cells, such as macrophages and T cells, become activated and start to phagocytose (engulf) pathogens or damaged tissue.
5. Increased heat production: Inflammation can cause an increase in metabolic activity in the affected tissue, leading to increased heat production.
6. Redness and swelling: Increased blood flow and leakiness of blood vessels can cause redness and swelling in the affected area.
7. Pain: Inflammation can cause pain through the activation of nociceptors (pain-sensing neurons) and the release of pro-inflammatory mediators.

Inflammation can be acute or chronic. Acute inflammation is a short-term response to injury or infection, which helps to resolve the issue quickly. Chronic inflammation is a long-term response that can cause ongoing damage and diseases such as arthritis, asthma, and cancer.

There are several types of inflammation, including:

1. Acute inflammation: A short-term response to injury or infection.
2. Chronic inflammation: A long-term response that can cause ongoing damage and diseases.
3. Autoimmune inflammation: An inappropriate immune response against the body's own tissues.
4. Allergic inflammation: An immune response to a harmless substance, such as pollen or dust mites.
5. Parasitic inflammation: An immune response to parasites, such as worms or fungi.
6. Bacterial inflammation: An immune response to bacteria.
7. Viral inflammation: An immune response to viruses.
8. Fungal inflammation: An immune response to fungi.

There are several ways to reduce inflammation, including:

1. Medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying anti-rheumatic drugs (DMARDs).
2. Lifestyle changes, such as a healthy diet, regular exercise, stress management, and getting enough sleep.
3. Alternative therapies, such as acupuncture, herbal supplements, and mind-body practices.
4. Addressing underlying conditions, such as hormonal imbalances, gut health issues, and chronic infections.
5. Using anti-inflammatory compounds found in certain foods, such as omega-3 fatty acids, turmeric, and ginger.

It's important to note that chronic inflammation can lead to a range of health problems, including:

1. Arthritis
2. Diabetes
3. Heart disease
4. Cancer
5. Alzheimer's disease
6. Parkinson's disease
7. Autoimmune disorders, such as lupus and rheumatoid arthritis.

Therefore, it's important to manage inflammation effectively to prevent these complications and improve overall health and well-being.

1. Preeclampsia: A condition characterized by high blood pressure during pregnancy, which can lead to complications such as stroke or premature birth.
2. Gestational diabetes: A type of diabetes that develops during pregnancy, which can cause complications for both the mother and the baby if left untreated.
3. Placenta previa: A condition in which the placenta is located low in the uterus, covering the cervix, which can cause bleeding and other complications.
4. Premature labor: Labor that occurs before 37 weeks of gestation, which can increase the risk of health problems for the baby.
5. Fetal distress: A condition in which the fetus is not getting enough oxygen, which can lead to serious health problems or even death.
6. Postpartum hemorrhage: Excessive bleeding after delivery, which can be life-threatening if left untreated.
7. Cesarean section (C-section) complications: Complications that may arise during a C-section, such as infection or bleeding.
8. Maternal infections: Infections that the mother may contract during pregnancy or childbirth, such as group B strep or urinary tract infections.
9. Preterm birth: Birth that occurs before 37 weeks of gestation, which can increase the risk of health problems for the baby.
10. Chromosomal abnormalities: Genetic disorders that may affect the baby's growth and development, such as Down syndrome or Turner syndrome.

It is important for pregnant women to receive regular prenatal care to monitor for any potential complications and ensure a healthy pregnancy outcome. In some cases, pregnancy complications may require medical interventions, such as hospitalization or surgery, to ensure the safety of both the mother and the baby.

The glucose tolerance test (GTT, not to be confused with GGT test) is a medical test in which glucose is given and blood ... "Glucose Tolerance Tests in Primary Care". Retrieved 2012-06-20. Jane Patmore (2009). "Oral Glucose Tolerance Tests: Protocol ... In the most commonly performed version of the test, an oral glucose tolerance test (OGTT), a standard dose of glucose is ... The glucose tolerance test was first described in 1923 by Jerome W. Conn. The test was based on the previous work in 1913 by A ...
While the regular glucose test is taken at a certain point in time, the glucose tolerance test involves repeated testing to ... Multiple tests for specific blood components, such as a glucose test or a cholesterol test, are often grouped together into one ... a visual test for blood left at crime scenes. Schumm test, a common test for blood mismatch Barbro Hjalmarsson Blood gas test " ... "Glucose tolerance test". Medline. Archived from the original on June 9, 2012. Retrieved June 21, 2012. Handbook of nutrition ...
Glucose loading test (GLT) - screens for gestational diabetes; if > 140 mg/dL, a glucose tolerance test (GTT) is administered; ... "Glucose challenge test - Mayo Clinic". www.mayoclinic.org. Retrieved 2022-04-29. "Glucose tolerance test - Mayo Clinic". www. ... Indirect Coombs test (AGT) to assess risk of hemolytic disease of the newborn Rapid plasma reagin test to screen for syphilis ... Nonstress test (NST) for fetal heart rate Oxytocin challenge test A pregnant woman may have a pre-existing disease, that may ...
"Glucose tolerance test data for Nsun2". Wellcome Trust Sanger Institute. "DEXA data for Nsun2". Wellcome Trust Sanger Institute ... Twenty eight tests were carried out on mutant mice and fourteen significant abnormalities were observed. Homozygous mutants ... were subviable and had decreased body weights, length of long bones and decreased circulating glucose levels, numerous abnormal ...
"Glucose tolerance test data for Slc16a2". Wellcome Trust Sanger Institute. "Clinical chemistry data for Slc16a2". Wellcome ... Twenty one tests were carried out on mutant mice and three significant abnormalities were observed. Female homozygote mutants ... This disease can be ruled out with a simple TSH/T4/T3 thyroid test. A conditional knockout mouse line, called Slc16a2tm1a(KOMP) ... had decreased circulating glucose levels. Male hemizygous mutants had an increased susceptibility to bacterial infection. Both ...
"Glucose tolerance test data for Akap9". Wellcome Trust Sanger Institute. "DEXA data for Akap9". Wellcome Trust Sanger Institute ... The remaining tests were carried out on both homozygous and heterozygous mutant adult mice. Animals of both sex displayed ... Twenty six tests were carried out on mutant mice and eight significant abnormalities were observed. Fewer than expected ...
"Glucose tolerance test data for Prkab1". Wellcome Trust Sanger Institute. "Clinical chemistry data for Prkab1". Wellcome Trust ... Homozygous mutant males displayed impaired glucose tolerance. Animals of both sex had increased circulating bilirubin levels, ... Twenty five tests were carried out on mutant mice and four significant abnormalities were observed. ... 2000). "Role of AMP-activated protein kinase in the regulation by glucose of islet beta cell gene expression". Proc. Natl. Acad ...
... female homozygotes displayed a decreased circulating glucose level after a glucose tolerance test. GRCh38: Ensembl release 89: ... "Glucose tolerance test data for Cyb561". Wellcome Trust Sanger Institute. "Salmonella infection data for Cyb561". Wellcome ... Twenty three tests were carried out on mutant mice and one significant abnormality was observed: ...
"Glucose tolerance test data for Grxcr1". Wellcome Trust Sanger Institute. "DEXA data for Grxcr1". Wellcome Trust Sanger ... improved glucose tolerance and a decreased leukocyte cell number. Female homozygotes also had an increased response to stress- ... Twenty four tests were carried out on mutant mice and thirteen significant abnormalities were observed. Homozygous mutant ... abnormal open field test and modified SHIRPA behaviour, and severe hearing impairment at 13 weeks. Male homozygous mutant ...
"Entrez Gene: PABPC4 poly(A) binding protein, cytoplasmic 4 (inducible form)". "Glucose tolerance test data for Pabpc4". ... female homozygous mutants displayed impaired glucose tolerance. PABPC4 has been shown to interact with PHLDA1. GRCh38: Ensembl ... Twenty tests were carried out on mutant mice and one significant abnormality was observed: ...
"Glucose tolerance test data for Cenpj". Wellcome Trust Sanger Institute. "DEXA data for Cenpj". Wellcome Trust Sanger Institute ... an impaired glucose tolerance, hypoalbuminemia, a 1.5 fold increase in micronuclei, a reduction in dentate gyrus length and ... Twenty five tests were carried out on mutant mice and thirteen significant abnormalities were observed. Homozygous mutants were ...
"Glucose tolerance test data for Myo7a". Wellcome Trust Sanger Institute. "DEXA data for Myo7a". Wellcome Trust Sanger Institute ... Male homozygous mutant mice displayed a decreased body weight, a decrease in body fat, improved glucose tolerance and abnormal ... Twenty three tests were carried out on mutant mice and ten significant abnormalities were observed. ... Homozygous mutant mice of both sex displayed various abnormalities in a modified SHIRPA test, including abnormal gait, tail ...
"Glucose tolerance test data for 4932414N04Rik". Wellcome Trust Sanger Institute. "Salmonella infection data for 4932414N04Rik ... Twenty two tests were carried out on mutant mice, but no significant abnormalities were observed. "RIKEN cDNA 4932414N04". ...
"Glucose tolerance test data for Kptn". Wellcome Trust Sanger Institute. "DEXA data for Kptn". Wellcome Trust Sanger Institute ... Female mice also had increased body weight, body fat and impaired glucose tolerance. Mutations in this gene have been ... Twenty two tests were carried out on mutant mice and six significant abnormalities were observed. Homozygous mutant mice had ...
... lower blood glucose and insulin levels following feeding; and better results for glucose and insulin tolerance tests. In a ... Deletion of the Lect2 gene in mice improves peripheral glucose entry into tissues. These studies suggest that mouse Lect2 ...
Obese children (BMI > 99.5) should undergo an oral glucose tolerance test each year. Even though a range of different screening ... The Review of Guidelines for Screening and Treatment affirms the use of fasting plasma glucose test (FPG) or a 2-hour plasma ... Most women with gestational diabetes will return to normal glucose levels after delivery of the baby; if a woman does not ... return to normal glucose levels she will be re-diagnosed with type 2 diabetes and is no longer considered to have gestational ...
... fasting plasma glucose (FPG): 10-16 hours after eating glucose tolerance test: continuous testing postprandial glucose test (PC ... MedlinePlus Encyclopedia: Glucose tolerance test "Is the glucose test during pregnancy optional? - Today's Parent". Today's ... 2 hours after eating random glucose test Some laboratory tests don't measure glucose levels directly from body fluids or ... 5.6-6 mmol/L (100-109 mg/dL) may indicate prediabetes and oral glucose tolerance test (OGTT) should be done for high-risk ...
"Glucose tolerance test data for Ldha". Wellcome Trust Sanger Institute. "Clinical chemistry data for Ldha". Wellcome Trust ... Animals of both sex had abnormal plasma chemistry, males also had improved glucose tolerance and increased red blood cell ... Twenty seven tests were carried out on mutant mice and five significant abnormalities were observed. Few homozygous mutant ... The remaining tests were carried out on heterozygous mutant adult mice. ...
AAS have been shown to alter fasting blood sugar and glucose tolerance tests. AAS such as testosterone also increase the risk ... Others: glucose intolerance, insulin resistance, immune dysfunction. Depending on the length of drug use, there is a chance ... Kidney tests revealed that nine of the ten steroid users developed a condition called focal segmental glomerulosclerosis, a ... Hepatic: elevated liver function tests (AST, ALT, bilirubin, LDH, ALP), hepatotoxicity, jaundice, hepatic steatosis, ...
They include hyperglycemia, hypoglycemia, impaired glucose tolerance test, impaired fasting glucose, among others. If blood ... The Mayo Clinic recommends emergency room treatment above 300 mg/dL blood glucose. The most common cause of hyperglycemia is ... Dysglycemia is a general definition for any abnormalities in blood glucose levels. ...
Issued on April 22, 2008 MedlinePlus Encyclopedia: Glucose tolerance test Huxley, Julian S. (1932). Problems of relative growth ... This is primarily used for diagnostic tests and screening tests, while monitoring tests may optimally be interpreted from ... Some important reference ranges in medicine are reference ranges for blood tests and reference ranges for urine tests. The ... Reference ranges for blood tests Reference ranges for urine tests Clinical pathology Joint Committee for Traceability in ...
Impaired glucose tolerance (IGT) is diagnosed with an oral glucose tolerance test. According to the criteria of the World ... Prediabetes can be diagnosed by measuring hemoglobin A1c, fasting glucose, or glucose tolerance test. Many people may be ... two-hour glucose levels of 140 to 199 mg per dL (7.8 to 11.0 mmol/L) on the 75-g oral glucose tolerance test. A patient is said ... but many have normal responses to a glucose tolerance test. Fasting glucose is helpful in identifying prediabetes when positive ...
Hermans MP, Levy JC, Morris RJ, Turner RC (1999). "Comparison of insulin sensitivity tests across a range of glucose tolerance ... an index for glucose tolerance, i.e. a measure for the ability to counteract the glucose load). Insulin is given in μU/mL. ... "Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes". Diabetes. 48 (9): 1779- ... Glucose and insulin are both during fasting. This model correlated well with estimates using the euglycemic clamp method (r = ...
Discovery of mild hyperglycemia during a routine glucose tolerance test for pregnancy is particularly characteristic. MODY ... when a high glucose is discovered during testing for other reasons, or screening of relatives of a person discovered to have ... The tools for management are similar for all forms of diabetes: blood testing, changes in diet, physical exercise, oral ... epidymal cysts in MODY type 5 The diagnosis of MODY is confirmed by specific gene testing available through commercial ...
Lab tests such as a UA, CBC, and glucose tolerance test are done if clinically indicated. In the third trimester the midwife ... Lab tests such as a CBC and UA may be done with additional testing done for at-risk pregnancies. The midwife palpates the ... Postnatal checks include neonatal screening test (NST, or heel prick test) around day five. The baby is weighed and the midwife ... and rubella testing. Additionally, women may have chlamydia testing via a urine sample, and women considered at high risk are ...
Glucose tolerance test: Oral glucose tolerance test (OGTT) used to assess the body's ability to metabolize glucose. Can be ... Liver Function Test: A series of tests used to assess liver function some of the tests are also used in the assessment of ... Serum cholinesterase test: a test of liver enzymes (acetylcholinesterase and pseudocholinesterase) useful as a test of liver ... The BUN test is primarily used to test kidney function. A low BUN level may indicate the effects of malnutrition. BUN-to- ...
However, in a study of four Space Shuttle astronauts by the same investigators, in which glucose tolerance tests were performed ... Maaß, H; Raabe, W.; Wegmann, H. M. (1995). "Effects of Microgravity on Glucose Tolerance". In Sahm, PR; Keller, MH; Schiewe, R ... bed rest studies simulating weightlessness in humans have shown an increased insulin response to glucose tolerance tests. In ... The entire test protocol was conducted three times within a 30-day period before lift-off. Postflight tests were conducted on ...
Three of the 5 studies used a reference 75 gram oral glucose tolerance test (OGTT) for at least one comparison; some studies ... A meta-analysis was conducted of the effect on postprandial glucose and insulin responses of adding a median of 5 grams of ... Additionally, allulose inhibits the absorption of glucose via transporters in the intestines. For these reasons, allulose has ... of postprandial glucose. The quality of the evidence was rated as moderate. The sweetness of allulose is estimated to be 70% of ...
Diagnosis of diabetes is by blood tests such as fasting plasma glucose, oral glucose tolerance test, or glycated hemoglobin ( ... or with a glucose tolerance test, two hours after the oral dose a plasma glucose ≥ 11.1 mmol/L (200 mg/dL) A random blood sugar ... Threshold for diagnosis of diabetes is based on the relationship between results of glucose tolerance tests, fasting glucose or ... A fasting or random blood sugar is preferred over the glucose tolerance test, as they are more convenient for people. HbA1c has ...
"Effects of oral glucosamine sulphate on serum glucose and insulin during an oral glucose tolerance test of subjects with ... Tannis AJ; Barban J; Conquer JA (June 2004). "Effect of glucosamine supplementation on fasting and non-fasting plasma glucose ...
Furthermore, sleep deprivation has been shown to decrease glucose tolerance and insulin sensitivity, and increase hunger and ... Being sleep-deprived for 24 hours leads to a dramatic decrease in cognitive performance tests similar to college exams, and ... The body's release of adrenaline and cortisol into the bloodstream causes an inability to process the glucose released by the ... Stress hormones in one's body directly affect glucose levels since the fight-or-flight response causes increased hormone levels ...
... growth hormone is not suppressed correctly during an oral glucose tolerance test). Such abnormalities in the insulin-like ... with correct suppression during an oral glucose tolerance test). In typical acromegaly disease scenario both insulin-like ...
Diabetes and impaired glucose tolerance are the most common causes. Hyperglycemia-induced formation of advanced glycation end ... These tests include a sweat test and a tilt table test. Diagnosis of small fiber involvement in peripheral neuropathy may also ... Laboratory tests include blood tests for vitamin B-12 levels, a complete blood count, measurement of thyroid stimulating ... Testing for small-fiber peripheral neuropathies often relates to the autonomic nervous system function of small thinly- and ...
To prevent the progression of symptoms of the disease, annual glucose tolerance tests beginning in early teen years to evaluate ... If the CP mutations has been identified in a related individual, prenatal testing is recommended. Siblings of those affected by ... Diagnosis of this disorder depends on blood tests demonstrating the absence of serum ceruloplasmin, combined with low serum ...
... with the two-hour value in oral glucose tolerance testing (OGTT), glucose rise in OGTT, waist-to-hip ratio, body fat content ( ... For diagnostic purposes, it is calculated from fasting insulin and glucose concentrations with: G ^ R = G 1 P ( ∞ ) ( D R + [ I ... Fasting blood glucose concentration (mg/dL) G1: Parameter for pharmacokinetics (154.93 s/L) DR: EC50 of insulin at its receptor ... and it correlates with the M value in glucose clamp studies, triceps skinfold, subscapular skinfold and (better than HOMA-IR ...
... resulting in improved glucose tolerance. As of 2015[update], those hypotheses continue to be tested, with Xiong et al. finding ... the secretion of the gut hormone GLP-1 and glucose-dependent insulin is more effectively promoted, improving glucose metabolism ... The duodenal-jejunal bypass liner is delivered endoscopically and has been tested on the morbidly obese (those with a body mass ... in 2006 produced two hypotheses for why duodenal-jejunal bypass is effective in improving glucose homeostasis. Their "hindgut ...
... improve glucose tolerance and also reduce adipose tissue inflammation. Palmitic acid esters of hydroxy-stearic acids (PAHSAs) ... FTY270 was further verified in clinical tests to have roles in immune modulation, such as that on multiple sclerosis. This ... This results in a substantial decrease in insulin responsiveness (i.e. to glucose) and in the death of insulin-producing cells ...
If the lactose cannot be digested, blood glucose levels will rise by less than 20 mg/dl. This test can be used to diagnose ... "Lactose tolerance tests". 3 May 2011. Archived from the original on 27 May 2016. National Digestive Diseases Information ... Other supporting tests include a hydrogen breath test and a stool acidity test. Other conditions that may produce similar ... "Lactose Intolerance Tests and Results". WebMD. Archived from the original on 2014-02-02. "Hydrogen Breath Test and Lactose ...
Intravenous glucose can also cause cholestasis as a result of increased fatty acid synthesis and decreased breakdown, which ... Additional imaging, laboratory testing, and biopsies might be conducted to identify the cause and extent of cholestasis. ALP ... A loss of immune tolerance is indicated by the presence of AMAs and autoreactive CD4+ and CD8+ T cells targeting cholangiocytes ... With a few exceptions, the optimal test for cholestasis would be elevations of serum bile acid levels. However, this is not ...
... treatment decreases the risk of developing type 2 diabetes mellitus in women with PCOS who exhibited impaired glucose tolerance ... "Laboratory Tests - Metformin". U.S. Food and Drug Administration (FDA). 5 June 2020. Retrieved 5 June 2020. This article ... In addition to suppressing hepatic glucose production, metformin increases insulin sensitivity, enhances peripheral glucose ... and decreases the absorption of glucose from the gastrointestinal tract. Increased peripheral use of glucose may be due to ...
The patient's blood test revealed iron levels of 2.3 mmol/L and hemoglobin level of 5.83 mmol/L. Normal iron blood levels of ... Post-operative gastric bypass patients develop a lowered tolerance for alcoholic beverages because their altered digestive ... initial clinical trials have produced promising results in the treatment's ability to improve weight loss and glucose ... A study conducted on 43 post-operative patients revealed that almost all of the patients tested positive for a hydrogen breath ...
Differences in drought tolerance was linked to directional changes in DNA-methylation levels throughout the genome, suggesting ... Moreover, the offspring born during the famine were found to have an increased risk of glucose intolerance in adulthood. ... and will need rigorous demonstration before studies explicitly testing the relative contributions of genotype, environment, and ... In one case, rice plants that were exposed to drought-simulation treatments displayed increased tolerance to drought after 11 ...
In 2014 a graphene based blood glucose testing product was announced. Graphene based FRET biosensors can detect DNA and the ... In 2016, Huawei announced graphene-assisted lithium-ion batteries with greater heat tolerance and twice the life span of ... In laboratory tests, the leading edge of a helicopter rotor blade was coated with the composite, covered by a protective metal ... In testing, the researchers charged and discharged the devices for thousands of cycles with almost no loss of capacitance. The ...
Tolerance development was marked in acute administration of cannabis in chronic hashish users. In testing narcotic antagonists ... glucose, ammonia, and hormones. Chemicals that affect brain functions change brain rhythms in systematic and identifiable ways ... Proposed psychoactive drugs developed in chemical laboratories were first tested in animals and then tested in man. The changes ... and the relation of evoked potentials to speech and psychological tests. Social changes in attitudes to the ethics of testing ...
The bacterium Lactobacillus sanfrancisco ferments maltose, but not glucose. Some glucose is provided by the action of the ... C. milleri and C. holmii are physiologically similar, but DNA testing established them as distinct. Other yeasts reported found ... S. cerevisiae has less tolerance to acetic acid than other sourdough yeasts. Continuously maintained, stable sourdough cannot ... Neubauer H, Glaasker E, Hammes WP, Poolman B, Konings WN (1994). "Mechanism of maltose uptake and glucose excretion in ...
Impacts of sleep deprivation are reduced glucose tolerance, elevated evening cortisol levels, and increased sympathetic nervous ... This is done through various cognitive tests and assessments. They will also look at research and potential treatment for ... "Dementia - Signs, Symptoms, Causes, Tests, Treatment, Care , alz.org". www.alz.org. Retrieved 2016-12-12. "Alzheimer's Disease ... neuropsychological tests and behavioral observations. Geriatric psychology began in 1978 with a spike in interest in mental ...
Tolerances ISO/R 966:1969 Seeds - Sampling and methods of test [Withdrawn without replacement] ISO/R 967:1969 Pesticides - ... 1980 Glucose syrups - Determination of dry matter - Vacuum oven method ISO 1743:1982 Glucose syrup - Determination of dry ... Uniaxial creep testing in tension - Method of test ISO/R 205:1961 Steel - Determination of proof stress and proving test at ... Fundamentals of testing glass ISO 1288-2:2016 Part 2: Coaxial double-ring test on flat specimens with large test surface areas ...
... to the close monitoring of TEDDY subjects through methods such as regular autoantibody testing and oral glucose tolerance tests ... TEDDY monitors participants for the presence of antibodies to insulin, GAD, IA2, and ZnT8 through regular testing. Study ...
"Effects of short-term cinnamon ingestion on in vivo glucose tolerance". Diabetes, Obesity & Metabolism. 9 (6): 895-901. doi: ... Although this has not been tested in humans, it is assumed that it could aid with the prevention of weight gain in humans, and ... As more GLUT4 receptors are present on the membrane more glucose is taken up into cells decreasing blood glucose levels which ... a threshold concentration of insulin is reached causing the cells to uptake glucose and therefore decreases blood glucose ...
Specifically, taking exogenous melatonin shortly after a meal is correlated with impaired glucose tolerance. Therefore, Rubio- ... Melatonin appears to cause very few side effects as tested in the short term, up to three months, at low doses.[clarification ... "Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening". Sleep. 37 (10): 1715-9. ... Garaulet M, Qian J, Florez JC, Arendt J, Saxena R, Scheer FA (March 2020). "Melatonin Effects on Glucose Metabolism: Time To ...
... and also reduced glucose and insulin levels in plasma after a glucose tolerance test. This indicates that weight loss from E- ...
In "Allen", she notices his nervousness as she tests for his glucose count to confirm his diabetes. However, she dismisses it ... However she warns him that he is developing a tolerance, and that they are no substitute for proper medical attention. ... Sara treats Michael after two of his toes are cut off in the episode "Cell Test", and the subsequent bonding between them turns ... after his test apparently passed (but only because Michael had taken insulin blockers to raise his blood sugar). Michael's ...
The majority of glucose degradation still occurs through anaerobic processes. Glycogen content in muscles reaches 35% in males ... Moreover, compared to those from neutral sites, acidic origin populations have higher embryonic and larval acid tolerance ( ... However, in the aforementioned Siberian and Danish populations mitochondrial DNA testing revealed that they were closely ... The manufacture of these products all requires the use of glucose, which is stored in a polymeric form, glycogen, in the ...
This includes decreased glucose tolerance and insensitivity to insulin. Sirolimus treatment may additionally increase the risk ... The safety of LAM treatment by sirolimus in people younger than 18 years old has not been tested. The antiproliferative effect ... Other mTOR inhibitors, such as temsirolimus (CCI-779) or everolimus (RAD001), are being tested for use in cancers such as ... As of 2016 rapamycin had been tested in small clinical trials in people with lupus. Lymphatic malformation, or cystic hygroma, ...
"Plasma levels of acylated ghrelin during an oral glucose tolerance test in obese children" (coauthor, 2007) "Is there any ... "Responses of lateral hyptohalamic glucose-sensitive and glucose-insensitive neurons to chemical stimuli in behaving rhesus ... "Feeding-related activity of glucose- and morphine-sensitive neurons in the monkey amygdala" (coauthor, 1986) " ... monkeys" (coauthor, 1992) "Glucose-sensitive neurons of the globus pallidus: I. Neurochemical characteristics" (coauthor, 1995 ...
Glucose tolerance test A test to see if a person has diabetes. The test is usually given in a lab or doctor's office in the ... Oral glucose tolerance test (OGTT) Oral hypoglycemic agents Pills or capsules that people take to lower the level of glucose ( ... Urine testing is less desirable than blood testing for monitoring the level of glucose in the body. See also: Blood glucose ... Latent diabetes Former term for impaired glucose tolerance. See also: Impaired glucose tolerance. Lente insulin A type of ...
"Effect of diet on the glucose tolerance and plasma insulin levels of the fat sand rat (Psammomys obesus)". Diabetes. 15 (2): ... Shenbrot, Georgy (2004). "Habitat Selection in a Seasonally Variable Environment: Test of the Isodar Theory with the Fat Sand ...
The test is often used to diagnose diabetes. ... The glucose tolerance test is a lab test to check how your body ... Oral glucose tolerance test - non-pregnant; OGTT - non-pregnant; Diabetes - glucose tolerance test; Diabetic - glucose ... The most common glucose tolerance test is the oral glucose tolerance test (OGTT). ... The test may take up to 3 hours.. A similar test is the intravenous (IV) glucose tolerance test (IGTT). It is rarely used, and ...
The test is often used to diagnose diabetes. ... The glucose tolerance test is a lab test to check how your body ... Oral glucose tolerance test - non-pregnant; OGTT - non-pregnant; Diabetes - glucose tolerance test; Diabetic - glucose ... The most common glucose tolerance test is the oral glucose tolerance test (OGTT). ... The test may take up to 3 hours.. A similar test is the intravenous (IV) glucose tolerance test (IGTT). It is rarely used, and ...
Dictionary Definition: oral glucose tolerance test. oral glucose tolerance test. A test to diagnose prediabetes and diabetes. ...
Beginning in 2005, an oral glucose tolerance test (OGTT) was added to the laboratory protocol. A fasting glucose blood test was ... Oral Glucose Tolerance Test (OGTT_F) Data File: OGTT_F.xpt First Published: January 2012. Last Revised: NA ... two-hour glucose tolerance data: GTDSCMMN is used to define "Glucose challenge Administer Time in minutes". GTDDR1MN is used to ... LBXGLT - Two Hour Glucose(OGTT) (mg/dL). Variable Name: LBXGLT. SAS Label: Two Hour Glucose(OGTT) (mg/dL). English Text: Two ...
Diabetes risk after a normal oral glucose tolerance test during pregnancy Greta Dubietyte 1 , Finn Friis Lauszus 1 , Arense ... Diabetes risk after a normal oral glucose tolerance test during pregnancy Greta Dubietyte et al. Dan Med J. 2022. . ... Glucose tolerance test with a single abnormal value in pregnancy and the risk of type-2 diabetes mellitus. Berezowsky A, Raban ... Antepartum glucose tolerance test results as predictors of type 2 diabetes mellitus in women with a history of gestational ...
Masoumeh Sadeghi, Hamidreza Roohafza, Shahin Shirani, Masoud Poormoghadas, Roya Kelishadi, Abdolmehdi Baghaii, Nizal Sarraf-Zadegan ...
While the appearance of glucose in the circulation has an important effect on FFA kinetics in MT, the rate of appearance of FFA ... Modeling glucose and free fatty acid kinetics in glucose and meal tolerance test Yanjun Li 1 , Carson C Chow 2 , Amber B ... Modeling glucose and free fatty acid kinetics in glucose and meal tolerance test Yanjun Li et al. Theor Biol Med Model. 2016. . ... The multiphasic profile of free fatty acids during the intravenous glucose tolerance test is unresponsive to exogenous insulin ...
Keywords: Gestational diabetes mellitus; Oral glucose tolerance test; glucose sample handling; insulin resistance ... The Diagnosis of Gestational Diabetes Mellitus Using a 75g Oral Glucose Tolerance Test: A Prospective Observational Study. 22 ... compared different sets of diagnostic cut-off points on plasma glucose measurements following a 75g Oral Glucose Tolerance Test ... The Diagnosis of Gestational Diabetes Mellitus Using a 75g Oral Glucose Tolerance Test: A Prospective Observational Study ( ...
Measurement of plasma insulin and growth hormone after oral glucose tolerance test in patients with alcoholic cirrhosis]. ... Significance of glucose load in oral glucose tolerance tests. Blood glucose, serum insulin, growth hormone and free fatty acids ... AdultAgedAlcoholismBlood GlucoseFatty Acids, NonesterifiedGlucose Tolerance TestGrowth HormoneHumansInsulinKineticsLiver ... Measurement of plasma insulin and growth hormone after oral glucose tolerance test in patients with alcoholic cirrhosis].. Arch ...
Both events were asymptomatic - I had no idea they happened until I checked continuous glucose monitor readings later. What ... Both events were asymptomatic - I had no idea they happened until I checked continuous glucose monitor readings later. What ... its a blood glucose spike, followed with a brief hypoglycemic episode. ... its a blood glucose spike, followed with a brief hypoglycemic episode. ...
Glucose tolerance testing is a tool used to estimate glucose effectiveness and insulin sensitivity in diabetic patients. The ... This study presents two mathematical models of a glucose tolerance test that incorporate glucose-insulin-glucagon dynamics. The ... Despite this, inclusion of glucagon activity when modelling the glucose kinetics during glucose tolerance testing is often ... Both models are validated against insulin-modified and glucose infusion intravenous glucose tolerance test (IVGTT) data, as ...
The most widely used classification of diabetes mellitus (DM) and allied categories of glucose intolerance is that recommended ... Oral Glucose Tolerance Test (OGTT). The standard oral glucose tolerance test (OGTT) involves measurement of plasma glucose ... Workup for the diagnosis of glucose intolerance include plasma glucose level, oral glucose tolerance testing, other screening ... Glucose Testing. Plasma glucose (PG) measurement is used as a screening test and for confirmation of a previously detected ...
Glucose Tolerance Test. An increase in blood glucose has been reported in patients receiving promethazine hydrochloride. ... Drug/Laboratory Test Interactions. The following laboratory tests may be affected in patients who are receiving therapy with ... Pregnancy Tests. Diagnostic pregnancy tests based on immunological reactions between HCG and anti-HCG may result in false- ...
Glucose Tolerance Test. An increase in blood glucose has been reported in patients receiving promethazine hydrochloride. ... Drug/Laboratory Test Interactions The following laboratory tests may be affected in patients who are receiving therapy with ... Pregnancy Tests. Diagnostic pregnancy tests based on immunological reactions between HCG and anti-HCG may result in false- ... Promethazine hydrochloride injection was nonmutagenic in the Salmonella test system of Ames. ...
Glucose Tolerance Test An increase in blood glucose has been reported in patients receiving promethazine hydrochloride. ... Pregnancy Tests Diagnostic pregnancy tests based on immunological reactions between HCG and anti-HCG may result in false- ... Drug/Laboratory Test Interactions. The following laboratory tests may be affected in patients who are receiving therapy with ... Specific studies to test the action of the drug on parturition, lactation, and development of the animal neonate were not done ...
... Stomati, M.;Bersi ... Beta-endorphin response to oral glucose tolerance test in obese and non-obese pre- and postmenopausal women / Stomati, M.*; ... demonstrated high plasma beta-EP levels in obese subjects and increased beta-EP release after an oral glucose tolerance test ( ... demonstrated high plasma beta-EP levels in obese subjects and increased beta-EP release after an oral glucose tolerance test ( ...
Learn about different kinds of diabetes tests and what the results mean. ... Random Blood Sugar Test. Result*. A1C Test. Fasting Blood Sugar Test. Glucose Tolerance Test. Random Blood Sugar Test. ... youll need to take a glucose tolerance test.. Glucose Tolerance Test. This measures your blood sugar before and after you ... Glucose Tolerance Test. This measures your blood sugar before and after you drink a liquid that contains glucose. Youll fast ( ...
Glucose tolerance tests. For glucose tolerance tests animals are fasted for 16 h and intraperitoneally injected with 1 g of ... D.- Glucose tolerance test of LWT and LΔRbfox2 fed a CD, (E.-) a HFD and (F.-) a HFr diet. G.- Blood analysis of LΔRbfox2 vs. L ... 4a-c) or glucose tolerance (Extended Data Fig. 4d-f) suggesting that RBFOX2 ablation does not interfere with normal liver ... Precursor ion tolerance was set at 20 ppm and product ion tolerance at 1 Da. Cysteine carbamidomethylation (+57.0215 Da) and ...
The oral glucose tolerance test (OGTT) was studied on 66 apparently normal persons (31 males and 35 females) of 20+ or -3 years ... The oral glucose tolerance test response in adults. Myanmar Health Sciences Research Journal. 1991; 3(2): 77-81. ... Urine sugar was tested at fasting state, after 1 hour and 2 hours of OGTT. The mean blood glucose levels at all points of OGTT ... although both groups showed normal response to oral glucose load. However, the blood glucose levels during OGTT of both groups ...
Continuous Glucose Monitoring: A Possible Aid for Detecting Hypoglycemic Events during Insulin Tolerance Tests. ... The combined pituitary function test evaluates the anterior pituitary gland, while the insulin tolerance test evaluates growth ... The CGM sensor glucose, BST, and serum glucose levels showed similar glucose trends in all three patients. A Bland-Altman ... Thus, CGM can be used as a safe aid for clinicians to use during insulin tolerance tests where critical hypoglycemia is induced ...
Text; Format: print Publication details: Genève : Organisation mondiale de la Santé, 2003Title translated: Laboratory diagnosis and monitoring of diabetes mellitus.; Diagnóstico y monitorización de la diabetes mellitus desde el laboratorio..Availability: Items available for loan: WHO HQ (2)Call number: WK 810 2003LA-1, ... ...
Glucose tolerance takes a look at manners to assess the potential of the frame to metabolize glucose, the foremost sort of ... What you can expect Glucose Tolerance Test. During the procedure Glucose Tolerance Test ... What Is a Glucose Tolerance Test?. Glucose tolerance takes a look at manners to assess the potential of the frame to metabolize ... Type 2 diabetes - Glucose Tolerance Test. If youre being tested for type 2 diabetes, two hours after drinking the glucose ...
This test detects blood sugar levels in people who may be pregnant or have diabetes or other conditions. Please make an ... Tests. Every week, our team completes up to 100,000 tests for patients around NSW. We accept all test referrals and we bulk ... If a test is not covered by Medicare, you will need to pay for your test. You can pay for your test: ... Test FAQs. Where can I go for my pathology test? Use our find a collection centre feature to find your nearest NSW Health ...
Clinical Chemistry (Glucose Tolerance Test) This interactive programme is intended as a compendium of modules on procedures in ... Quiz/Test. Author:. SnagApp Date Created:. December 3, 2014. Date Modified:. August 10, 2021. ...
... see glucose tolerance test. Source for information on impaired glucose tolerance: A Dictionary of Nursing dictionary. ... Acceptance testing , acceptance testing See testing. See also review. system testing See testing. Psychological Tests , ... Schilling Test , Schilling test (shil-ing) n. a test used to assess a patients capacity to absorb vitamin B12 from the bowel. ... parametric test , parametric test (pa-ră-met-rik) n. a test of statistical significance based on the assumption that the range ...
Most specialists suggest a glucose resilience test towards the center of the ... Glucose Tolerance Test During Pregnancy. The GTT test is generally stayed away from by numerous ladies as it very well may be ... Glucose levels following an hour of glucose utilization - 180 mg/dL. Glucose levels following two hours of glucose utilization ... Tips For How take Glucose Tolerance Test During Pregnancy. By Cristina Railsback On Mar 26, 2015. ...
Oral glucose tolerance testing (OGTT). *Overnight observation. *Patient education. *Patient monitoring. *Pelvic and/or breast ... Point of care testing (pregnancy, rapid influenza A & B, blood glucose, hematocrit, cotinine tests) ... Human biospecimen testing services:. *Bar-coded labels and sample tracking utilizing BSI® ... Customizable Architect i1000SR chemiluminescent immunoassay analyzer capable of testing 147 different hormones and cytokines * ...
Context: Oral glucose tolerance test (OGTT)-related hypoglycemia is common in pancreatic-insufficient cystic fibrosis (PI-CF), ... N2 - Context: Oral glucose tolerance test (OGTT)-related hypoglycemia is common in pancreatic-insufficient cystic fibrosis (PI- ... AB - Context: Oral glucose tolerance test (OGTT)-related hypoglycemia is common in pancreatic-insufficient cystic fibrosis (PI- ... abstract = "Context: Oral glucose tolerance test (OGTT)-related hypoglycemia is common in pancreatic-insufficient cystic ...
Repeating an oral glucose tolerance test. (4) Pulmonary function and disease:. Spirometry was performed in CARDIA at baseline ... These instruments include the Rey-Auditory Verbal Learning Test, the Digit Symbol Substitution Test, and the Stroop Test. An ... Including a reading test, such as the National Adult Reading Test (NART). The Wechsler Adult Intelligence Scale-Revised (WAIS-R ... Including a test of attention and reaction time, such as the Flanker Test ...
... glucose tolerance test; Hct = hematocrit; NIPS = noninvasive prenatal screening; NST = nonstress test; NT = nuchal translucency ... Test performance similar to that in non-obese patients. Testing performance is compromised by obesity, and this is "dose" based ... For BMI of 35.0-39.9 kg/m2, consider weekly antenatal testing starting at 37 weeks gestation ... For patients with BMI of 35.0-39.9, consider weekly antenatal testing starting at 37 weeks gestation ...
  • The most common glucose tolerance test is the oral glucose tolerance test (OGTT). (medlineplus.gov)
  • The OGTT is used to screen for or diagnose diabetes in people with a fasting blood glucose level that is high, but is not high enough (above 125 mg/dL or 7 mmol/L) to meet the diagnosis for diabetes. (medlineplus.gov)
  • Also called OGTT or glucose tolerance test. (nih.gov)
  • Diabetes mellitus was assessed by measures of fasting plasma glucose, two-hour glucose (OGTT) and serum insulin in participants, aged 12 years and over, who were examined in the morning (AM) session only. (cdc.gov)
  • Beginning in 2005, an oral glucose tolerance test (OGTT) was added to the laboratory protocol. (cdc.gov)
  • Our aim was to conduct a follow-up of a cohort of women screened for GDM with a normal oral glucose tolerance test (OGTT) during pregnancy to investigate the incidence and time of diagnosis of manifest diabetes mellitus and identify risk factors for subsequent development of diabetes. (nih.gov)
  • A normal fasting glucose and also a borderline fasting glucose at OGTT during pregnancy were associated with an increased risk of manifest diabetes (p less-than 0.001), also after adjustment for age, Body Mass Index, non-Danish origin and smoking during pregnancy (p less-than 0.002). (nih.gov)
  • This prospective study compared different sets of diagnostic cut-off points on plasma glucose measurements following a 75g Oral Glucose Tolerance Test (OGTT). (ssrn.com)
  • [ 1 , 4 ] The one-step approach involves performing a 75-g OGTT, with plasma glucose measurement when the patient is fasting and at 1 and 2 hours in this group of gravida at 24-28 weeks' gestation. (medscape.com)
  • If the plasma glucose level after 1 hours is ≥130 mg/dL, 135 mg/dL, or 140 mg/dL (7.2 mmol/L, 7.5 mmol/L, or 7.8 mmol/L, respectively), perform a fasting 100-g OGTT. (medscape.com)
  • Previous clinical studies have demonstrated high plasma beta-EP levels in obese subjects and increased beta-EP release after an oral glucose tolerance test (OGTT) in normal or obese women. (unifi.it)
  • The aim of the present study was to evaluate plasma beta-endorphin levels in response to an OGTT in pre- and postmenopausal obese and non-obese women, in order to investigate if the decrease in gonadal steroid levels at menopause could modify in a different manner the control of beta-endorphin release in response to glucose administration. (unifi.it)
  • The oral glucose tolerance test (OGTT) was studied on 66 apparently normal persons (31 males and 35 females) of 20+ or -3 years group and 68 apparently normal persons (33 males and 35 females) of 50+ or -3 years group. (who.int)
  • Urine sugar was tested at fasting state, after 1 hour and 2 hours of OGTT. (who.int)
  • Context: Oral glucose tolerance test (OGTT)-related hypoglycemia is common in pancreatic-insufficient cystic fibrosis (PI-CF), but its mechanistic underpinnings are yet to be established. (wustl.edu)
  • Conclusions: OGTT-related hypoglycemia in PI-CF is associated with elevated 1-hour glucose, impaired early phase insulin secretion, higher late insulin exposure, and less increase in glucagon and FFAs. (wustl.edu)
  • Oral glucose tolerance test (OGTT) of 8 week old TALLYHO/JngJ males. (jax.org)
  • Abnormal glucose tolerance (blood sugar goes too high during the glucose challenge) is an earlier sign of diabetes than an abnormal fasting glucose. (medlineplus.gov)
  • It most usually is used during being pregnant to locate early glucose intolerance that would pose a big danger to the infant if the circumstance advanced to gestational diabetes mellitus. (usa-good.com)
  • Glucose intolerance by 8 weeks (Figure 3). (jax.org)
  • Glucose intolerance by 8 weeks of age. (jax.org)
  • A 2-hour value of 140 to 199 mg/dL (7.8 and 11.1 mmol/L) is called impaired glucose tolerance. (medlineplus.gov)
  • Any glucose level of 200 mg/dL (11.1 mmol/L) or higher is used to diagnose diabetes. (medlineplus.gov)
  • The fasting glucose value in mg/dL (LBXGLT) was converted to mmol/L (LBDGLTSI) by multiplying by 0.05551 (rounded to 3 decimals). (cdc.gov)
  • Abnl-GT is a term which includes both diabetes and prediabetes and was defined as fasting plasma glucose (FPG) ≥5.6 mmol/L and/or 2-hour glucose ≥7.8 mmol/L. IR was defined by the lowest quartile of the Matsuda Index (≤2.98) and retested using the upper quartile of homeostatic model assessment of insulin resistance (HOMA-IR) (≥2.07). (bmj.com)
  • Tests to screen for diabetes during pregnancy are similar, but are done differently. (medlineplus.gov)
  • [ 4 ] Use only plasma glucose criteria to diagnose diabetes in the setting of conditions associated with an altered relationship between HBA1C and glycemia (eg, sickle cell disease, second and third pregnancy trimesters and the postpartum period, glucose-6-phosphate dehydrogenase deficiency, infection with human immunodeficiency virus, hemodialysis, recent blood loss or transfusion, or erythropoietin therapy). (medscape.com)
  • You'll probably be tested between 24 and 28 weeks of pregnancy. (cdc.gov)
  • More normally, a modified model of the glucose tolerance test is used to diagnose gestational diabetes - a type of diabetes that develops in the course of pregnancy. (usa-good.com)
  • Most specialists suggest a glucose resilience test towards the center of the pregnancy to check for gestational diabetes. (motherabroad.com)
  • What tests might I need during pregnancy? (nih.gov)
  • Every woman has certain tests during pregnancy. (nih.gov)
  • If you are at high risk-for example, if you have a family history of diabetes, are obese, had a large baby in a previous pregnancy, or are having twins-you should discuss this with your health care provider get a test for blood glucose earlier in your pregnancy. (nih.gov)
  • This test is performed between 35 and 37 weeks of pregnancy to look for bacteria (GBS) that can cause pneumonia or other serious infections in your infant. (nih.gov)
  • This screening test is done between 15 and 20 weeks of pregnancy. (nih.gov)
  • Given between 15 and 20 weeks of pregnancy, this test is used to diagnose chromosomal disorders, such as Down syndrome and your infant's risk for NTDs, such as spina bifida. (nih.gov)
  • Background: Gestational diabetes mellitus (‎GDM)‎ is defined as impaired glucose tolerance with onset during the second or third trimester of pregnancy.Aims: The purpose of this study was to investigate the prevalence of pregnant women who were not screened for gesta-tional diabetes mellitus and compare the maternal and fetal outcomes of women who had undergone GDM screening. (who.int)
  • During pregnancy, you'll discover that there are many prenatal screening tests that your doctor will recommend. (adoption.com)
  • This common test helps determine if your pregnancy is an ectopic or tubal pregnancy. (adoption.com)
  • If you experience complications or bleeding during your pregnancy, ultrasound testing may be one of your options, since it can also help understand the baby's vitality. (adoption.com)
  • Ultrasound testing can be performed throughout the entirety of your pregnancy. (adoption.com)
  • This test is commonly completed toward the end of your pregnancy, before labor and delivery. (adoption.com)
  • Like the Stress Test, the Non-Stress Test is usually performed at the end of your pregnancy. (adoption.com)
  • Prenatal screening tests are very important for a healthy and happy pregnancy. (adoption.com)
  • One of the most common uses of the 1-hour glucose test is the diagnosis of diabetes during pregnancy ( gestational diabetes ), which can be dangerous for both the mother and baby. (medicinenet.com)
  • Kramb J. 1-Hour Glucose Tolerance Test in Pregnancy. (medicinenet.com)
  • You'll need to get your blood sugar tested to find out for sure if you have prediabetes or type 1 , type 2 , or gestational diabetes. (cdc.gov)
  • Ask your health care provider what your results mean if you're being tested for gestational diabetes. (cdc.gov)
  • Gestational diabetes is diagnosed using blood tests. (cdc.gov)
  • If your risk is higher for getting gestational diabetes (due to having more risk factors), your doctor may test you earlier. (cdc.gov)
  • If your test results show you have type 1, type 2, or gestational diabetes, talk with your doctor or nurse about a detailed treatment plan-including diabetes self-management education and support services -and specific steps you can take to be your healthiest. (cdc.gov)
  • Disappointment in the glucose resilience test would imply that the lady has gestational diabetes or is in the high danger classification of creating gestational diabetes. (motherabroad.com)
  • In 5 hour GTT, the blood will be tried for gestational diabetes following five hours of controlling the glucose syrup. (motherabroad.com)
  • Methods: Women who refused to attend the gestational diabetes screening test (‎n = 162)‎ at a maternity hospital in An-kara, Turkey, between October 2014 and January 2015 were included in this prospective cohort study. (who.int)
  • Conclusions: Fasting and postprandial plasma glucose screening can replace gestational diabetes mellitus screening in women who refuse to have the glucose load test. (who.int)
  • This test is to determine whether or not you suffer from gestational diabetes. (adoption.com)
  • You may have your urine tested for ketones (produced when your body burns fat for energy), which also indicate type 1 diabetes instead of type 2 diabetes. (cdc.gov)
  • Samples of blood and urine for glucose determination are obtained half-hour, 1 hour, 2 hours, and 3 hours later. (usa-good.com)
  • Urine test. (nih.gov)
  • At each prenatal visit, you will give a urine sample, which will be tested for signs of diabetes, urinary tract infections, and preeclampsia. (nih.gov)
  • The evaluation includes blood and urine tests, imaging tests, dexamethasone and corticotropin-releasing hormone tests and inferior petrosal sinus sampling. (nih.gov)
  • The two-step approach is a 1-hour (nonfasting) plasma glucose measurement after a 50-g oral glucose load in women at 24-48 weeks' gestation who were not previously diagnosed with diabetes. (medscape.com)
  • 0.01), although both groups showed normal response to oral glucose load. (who.int)
  • A plasma glucose level above 140 mg/a hundred ml suggests the need for a glucose tolerance take a look at. (usa-good.com)
  • Close medical supervision for glucose monitoring is required during hypoglycemia induction and the test is often very tedious. (bvsalud.org)
  • We provide three cases in which CGM was successfully used alongside a standard BST and serum glucose levels during the combined pituitary function test to better detect and induce hypoglycemia . (bvsalud.org)
  • The CGM sensor glucose and BST levels were simultaneously assessed for glycemic changes and when adequate hypoglycemia was reached during the combined pituitary function test . (bvsalud.org)
  • Thus, CGM can be used as a safe aid for clinicians to use during insulin tolerance tests where critical hypoglycemia is induced. (bvsalud.org)
  • After the initial venipuncture, participants were asked to drink a calibrated dose (generally 75 grams of glucose) of TrutolTM and had a second venipuncture 2 hours (plus or minus 15 minutes) after drinking the Trutol. (cdc.gov)
  • The most commonplace procedure is to take a preliminary blood sample from a fasting character, have the man or woman empty his or her bladder, and then administer orally 50-100 grams of glucose (commonly 1 gram of glucose consistent with kilogram of ideal frame weight) dissolved in water. (usa-good.com)
  • After a fasting blood glucose test end result has been acquired, 75 grams of glucose (100 g if the affected person is pregnant) is run and blood samples are taken every half-hour for 2 hours. (usa-good.com)
  • You will then be asked to drink a liquid containing a certain amount of glucose (usually 75 grams). (medlineplus.gov)
  • In men and women with everyday or barely multiplied blood-sugar stages, the body tolerance to sugar is measured in a disturbing situation brought about through administering a large amount of glucose. (usa-good.com)
  • A fasting glucose tolerance check can convey important data about the approximately decreased tolerance to sugar in individuals tormented by an impairment of sugar metabolism, together with diabetes mellitus. (usa-good.com)
  • An oral glucose tolerance test is used to verify or exclude the analysis of diabetes mellitus while a fasting blood glucose test end result isn't definitive (i.E., greater than the higher variety of the normal fee but less than the diagnostic level for diabetes). (usa-good.com)
  • The prevalence of diabetes mellitus (DM) and impaired glucose tolerance (IGT) has increased worldwide, although their prevalence and determinants among Tibetans are currently unknown. (oncotarget.com)
  • 16. The effect of cilostazol on glucose tolerance and insulin resistance in a rat model of non-insulin dependent diabetes mellitus. (nih.gov)
  • A similar test is the intravenous (IV) glucose tolerance test (IGTT). (medlineplus.gov)
  • Both models are validated against insulin-modified and glucose infusion intravenous glucose tolerance test (IVGTT) data, as well as insulin infusion data, and are capable of estimating patient glucose effectiveness (sG) and insulin sensitivity (sI). (ljmu.ac.uk)
  • The importance of such tests has prompted the development and utilisation of mathematical models that describe glucose kinetics as a function of insulin activity. (ljmu.ac.uk)
  • Despite this, inclusion of glucagon activity when modelling the glucose kinetics during glucose tolerance testing is often overlooked. (ljmu.ac.uk)
  • A less difficult but less-reliable screening check is the 2-hour postprandial blood glucose test. (usa-good.com)
  • Glucose tolerance testing is a tool used to estimate glucose effectiveness and insulin sensitivity in diabetic patients. (ljmu.ac.uk)
  • A similar test is used in the diagnosis of growth hormone excess (acromegaly) when both glucose and growth hormone are measured after the glucose drink is consumed. (medlineplus.gov)
  • The combined pituitary function test evaluates the anterior pituitary gland , while the insulin tolerance test evaluates growth hormone deficiencies. (bvsalud.org)
  • A test to diagnose prediabetes and diabetes. (nih.gov)
  • If your test results show you have prediabetes, ask your doctor or nurse if the lifestyle change program offered through the CDC-led National Diabetes Prevention Program is available in your community. (cdc.gov)
  • It is anticipated that between 2019 and 2045, Africa will experience a 143% increase in the prevalence of abnormal glucose tolerance, a term which combines diabetes and prediabetes. (bmj.com)
  • In addition, a capillary blood sugar test (BST) and serum glucose levels may differ greatly. (bvsalud.org)
  • The CGM sensor glucose , BST, and serum glucose levels showed similar glucose trends in all three patients . (bvsalud.org)
  • To avoid misdiagnosis or missed diagnosis, perform HBAIC testing with a method that is certified by the NGSP and standardized to the Diabetes Control and Complications Trial (DCCT) assay. (medscape.com)
  • If unequivocal hyperglycemia is absent, the diagnosis requires two abnormal test results from the same sample or in two separate test samples. (medscape.com)
  • Blood is drawn to test for PAPP-A and free beta-hCG (or hCG) and may be combined with performing a nuchal translucency ultrasound. (nih.gov)
  • The examples above are common measurements for results of these tests. (medlineplus.gov)
  • Some labs use different measurements or test different samples. (medlineplus.gov)
  • A Bland-Altman analysis revealed that the CGM underestimated the BST values by approximately 9.68 mg/dL, and a Wilcoxon signed-rank test showed that the CGM and BST measurements significantly differed during the stimulation test (p = 0.003). (bvsalud.org)
  • Blood glucose measurements were obtained using a OneTouch ® Ultra hand-held glucometer. (jax.org)
  • People with untreated diabetes have high blood glucose levels. (medlineplus.gov)
  • In the presence of marked discordance between measured and plasma glucose levels of HBA1C, consider the possibility of HBA1C assay interference from hemoglobin variants (ie, hemoglobinopathies), and consider use of an assay without interference or plasma glucose criteria to diagnose diabetes. (medscape.com)
  • A significant increase in plasma beta-EP levels, at 30 and 60 minutes after oral glucose ingestion, was shown in control premenopausal women. (unifi.it)
  • This test detects blood sugar levels in people who may be pregnant or have diabetes or other conditions. (nsw.gov.au)
  • You will consume a sugary drink and get a blood test 1 hour later to measure your blood sugar levels. (nih.gov)
  • When glucose enters the bloodstream, blood sugar levels go up. (kidshealth.org)
  • This test shows a person's average blood sugar levels over the past few months. (kidshealth.org)
  • A first blood sample will be taken on arrival before you consume a glucose drink. (nsw.gov.au)
  • Fasting means that you cannot consume food or drinks (except water) for a specified amount of time before your test. (nsw.gov.au)
  • You will be required to consume a glucose-containing beverage. (medicinenet.com)
  • Your blood will be taken 1 hour after you consume the glucose solution to determine your blood glucose level. (medicinenet.com)
  • Do not eat or drink anything for at least 8 hours before the test. (medlineplus.gov)
  • This check is finished 2 hours after intake of a preferred glucose answer or a meal containing a hundred grams of carbohydrates. (usa-good.com)
  • The glucose tolerance check identifies abnormalities inside the manner your body handles glucose after a meal - frequently before your fasting blood glucose level will become unusual.The glucose tolerance taken a look at is one way to evaluate how nicely your frame metabolizes glucose. (usa-good.com)
  • High alcohol consumption increases the risk of abnormal glucose regulation in men. (nih.gov)
  • 11. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. (nih.gov)
  • An answer of glucose is given to the pregnant lady and following an hour of pausing, the specialist checks the blood to perceive how well the sugar has been prepared. (motherabroad.com)
  • The pregnant lady will then, at that point be given glucose syrup on a vacant stomach. (motherabroad.com)
  • In the event that a pregnant lady comes up short both the tests, she will be in the high danger class and would require expanded observing and food control to keep the child protected and solid. (motherabroad.com)
  • If your fetus is at risk for a chromosomal defect or other genetic disorders, your doctor may recommend this test when you are between 10 and 13 weeks pregnant. (nih.gov)
  • Some tests are screening tests, and others are diagnostic tests. (nih.gov)
  • If your health care provider orders a screening test, keep in mind that such tests do not diagnose problems. (nih.gov)
  • So a screening test result that comes back abnormal does not mean there is a problem with your infant. (nih.gov)
  • Glucose challenge screening. (nih.gov)
  • This screening test uses ultrasonography to measure the thickness of the back of the fetus's neck between 11 and 14 weeks. (nih.gov)
  • This test can be given as early as 10 weeks to women whose age, family history, or standard screening results put them at higher risk for having a child with a chromosome disorder. (nih.gov)
  • Women who did not attend GDM screening test had increased risk for mild idiopathic polyhydramnios in late gestation. (who.int)
  • The same is true for prenatal screening tests. (adoption.com)
  • If you are aware of the common prenatal screening tests, you'll be able to ask relevant and applicable questions. (adoption.com)
  • Doctors perform prenatal screening tests because it can identify if there are any health issues or conditions for both you and your baby. (adoption.com)
  • Prenatal screening tests also include finding out the gender, general size, placement within the uterus, and age. (adoption.com)
  • Below is a list of some common prenatal screening tests. (adoption.com)
  • Like many of the other common prenatal screening tests, this test can help you prepare for any special care that your child may need-whether that is prenatally or after birth. (adoption.com)
  • They will inform you of the screening procedure and whether there are specific instructions you must follow to ensure that the findings of the tests are accurate. (medicinenet.com)
  • Taylor M. Glucose Screening and Glucose Tolerance Test. (medicinenet.com)
  • In the event that the sugar isn't handled well, i.e., if the sugar level is between 140 mg/dL and 200 mg/Dl, a three hour GTT test will be suggested by your primary care physician. (motherabroad.com)
  • If your doctor thinks you have type 1 diabetes, your blood may also tested for autoantibodies (substances that indicate your body is attacking itself) that are often present in type 1 diabetes but not in type 2 diabetes. (cdc.gov)
  • How you prepare for the 1-hour glucose test depends on which type has been requested by your physician. (medicinenet.com)
  • Before the test begins, when you have had nothing to eat or drink for at least 8 hours, a sample of blood will be taken. (medlineplus.gov)
  • The test may take up to 3 hours. (medlineplus.gov)
  • Capillary blood samples of fasting and half hourly samples after the glucose load were determined for 2 hours by O-toludine method. (who.int)
  • Normally the awareness of glucose in the blood will upward thrust to approximately a hundred and forty mg/one hundred ml within 45-60 mins and will go back in 1 half of-2 1/2 hours to the regular range of 80-a hundred and twenty mg/100 ml. (usa-good.com)
  • Even if a blood glucose test is received after fasting 10-12 hours and the level is above 140 mg/100 ml, it's crucial to verify the result with a 2nd determination to rule out different elements which can have given a one-time atypical take a look at the end result. (usa-good.com)
  • To get this test, a person first stops eating for at least 8 hours. (kidshealth.org)
  • For the glucose tolerance tests, mice were fasted 14-16 hours and glucose was administered by oral gavage at 2g/kg body weight. (jax.org)
  • For 8-14 hours before this test, you must refrain from eating or drinking anything (except a few sips of water). (medicinenet.com)
  • You will need to visit the lab just once for the 1-step glucose test and the process will last 2 hours. (medicinenet.com)
  • Both events were asymptomatic - I had no idea they happened until I checked continuous glucose monitor readings later. (tedeytan.com)
  • Continuous Glucose Monitoring: A Possible Aid for Detecting Hypoglycemic Events during Insulin Tolerance Tests. (bvsalud.org)
  • An alternative approach may be utilizing a continuous glucose - monitoring (CGM) system. (bvsalud.org)
  • After we eat, carbohydrates in food break down into glucose. (kidshealth.org)
  • Subjects, who at baseline had normal glucose tolerance (2070 men and 3058 women) or pre-diabetes (70 men and 41 women), aged 35-56 years, were evaluated in this cohort study. (nih.gov)
  • This step will determine whether your blood glucose level is high or normal. (medicinenet.com)
  • Success in avoiding diabetic complications has a very large part to do with identification, admission and subsequent removal of the glucose foods - grain, starch, sugar and froot - as they are the most potent culprit in rollercoaster, elevated blood glucose. (tedeytan.com)
  • 14. Plasma glucose-lowering action of Hon-Chi in streptozotocin-induced diabetic rats. (nih.gov)
  • 18. GABA dramatically improves glucose tolerance in streptozotocin-induced diabetic rats fed with high-fat diet. (nih.gov)
  • The hormone glucagon, also plays a fundamental role in systemic plasma glucose regulation and is secreted reciprocally to insulin, stimulating catabolic glucose utilisation. (ljmu.ac.uk)
  • Glucose concentration was determined by a hexokinase method. (cdc.gov)
  • The models are used to investigate how different degrees of pax'tient glucagon sensitivity and effectiveness affect the concentration of blood glucose and plasma glucagon during IVGTT and insulin infusion tests, providing a platform from which the role of glucagon dynamics during a glucose tolerance test may be investigated and predicted. (ljmu.ac.uk)
  • The glucose tolerance test is a lab test to check how your body moves sugar from the blood into tissues like muscle and fat. (medlineplus.gov)
  • Glucose is the sugar the body uses for energy. (medlineplus.gov)
  • The test is done to decide the productivity of the body in preparing the sugar. (motherabroad.com)
  • Insulin helps open cells throughout the body to let glucose in, giving the cells the energy they need. (kidshealth.org)
  • When there's not enough insulin in the body to let the glucose into the cells, the body starts to break down fat instead of sugar. (kidshealth.org)
  • The test is ordinarily planned towards the finish of the subsequent trimester. (motherabroad.com)
  • Vigorous exercise can lower your blood glucose level. (medlineplus.gov)
  • Some medicines can raise or lower your blood glucose level. (medlineplus.gov)
  • The A1C test measures your average blood sugar level over the past 2 or 3 months. (cdc.gov)
  • You'll fast (not eat) overnight before the test and have your blood drawn to determine your fasting blood sugar level. (cdc.gov)
  • You'll drink a liquid that contains glucose, and then 1 hour later your blood will be drawn to check your blood sugar level. (cdc.gov)
  • If your level is higher than 140 mg/dL, you'll need to take a glucose tolerance test. (cdc.gov)
  • When glucose can't get into cells, the blood sugar level rises. (kidshealth.org)
  • Each time, your blood glucose level will be measured. (medicinenet.com)
  • In patients with diabetes, the blood glucose cost will upward push to a higher degree and continue to be better longer than in those who do not have diabetes. (usa-good.com)
  • Every week, our team completes up to 100,000 tests for patients around NSW. (nsw.gov.au)
  • Ask your health care provider if any of the medicines you take can affect the test results. (medlineplus.gov)
  • Your health care provider can explain what the test results mean and possible next steps. (nih.gov)
  • With the blood test, some people feel nauseated, sweaty, lightheaded, or may even feel short of breath or faint after drinking the glucose. (medlineplus.gov)
  • A fasting glucose blood test was performed on all participants, 12 years and older, who were examined in the morning session, after a 9 hour fast. (cdc.gov)
  • Results can differ depending on the size of the glucose drink and how often your blood sugar is tested. (cdc.gov)